
Treatment Plans
- 59 installs
- 51 repo stars
- Updated November 25, 2025
- ovachiever/droid-tings
Helps with ai & agent building tasks during AI-assisted development.
About
treatment-plans is a Claude Code skill for ai & agent building. It helps solo builders move faster with AI-assisted coding.
- treatment-plans
- AI & Agent Building
- AI-coding skill
Treatment Plans by the numbers
- 59 all-time installs (skills.sh)
- Ranked #6,379 of 16,556 AI & Agent Building skills by installs in the Skillselion catalog
- Data as of Jul 27, 2026 (Skillselion catalog sync)
npx skills add https://github.com/ovachiever/droid-tings --skill treatment-plansAdd your badge
Show developers this skill is listed on Skillselion. Paste this into your README.
| Installs | 59 |
|---|---|
| repo stars | ★ 51 |
| Last updated | November 25, 2025 |
| Repository | ovachiever/droid-tings ↗ |
What it does
Helps with ai & agent building tasks during AI-assisted development.
Files
Treatment Plan Writing
Overview
Treatment plan writing is the systematic documentation of clinical care strategies designed to address patient health conditions through evidence-based interventions, measurable goals, and structured follow-up. This skill provides comprehensive LaTeX templates and validation tools for creating concise, focused treatment plans (3-4 pages standard) across all medical specialties with full regulatory compliance.
Critical Principles: 1. CONCISE & ACTIONABLE: Treatment plans default to 3-4 pages maximum, focusing only on clinically essential information that impacts care decisions 2. Patient-Centered: Plans must be evidence-based, measurable, and compliant with healthcare regulations (HIPAA, documentation standards) 3. Minimal Citations: Use brief in-text citations only when needed to support clinical recommendations; avoid extensive bibliographies
Every treatment plan should include clear goals, specific interventions, defined timelines, monitoring parameters, and expected outcomes that align with patient preferences and current clinical guidelines - all presented as efficiently as possible.
When to Use This Skill
This skill should be used when:
- Creating individualized treatment plans for patient care
- Documenting therapeutic interventions for chronic disease management
- Developing rehabilitation programs (physical therapy, occupational therapy, cardiac rehab)
- Writing mental health and psychiatric treatment plans
- Planning perioperative and surgical care pathways
- Establishing pain management protocols
- Setting patient-centered goals using SMART criteria
- Coordinating multidisciplinary care across specialties
- Ensuring regulatory compliance in treatment documentation
- Generating professional treatment plans for medical records
Document Format and Best Practices
Document Length Options
Treatment plans come in three format options based on clinical complexity and use case:
Option 1: One-Page Treatment Plan (PREFERRED for most cases)
When to use: Straightforward clinical scenarios, standard protocols, busy clinical settings
Format: Single page containing all essential treatment information in scannable sections
- No table of contents needed
- No extensive narratives
- Focused on actionable items only
- Similar to precision oncology reports or treatment recommendation cards
Required sections (all on one page): 1. Header Box: Patient info, diagnosis, date, molecular/risk profile if applicable 2. Treatment Regimen: Numbered list of specific interventions 3. Supportive Care: Brief bullet points 4. Rationale: 1-2 sentence justification (optional for standard protocols) 5. Monitoring: Key parameters and frequency 6. Evidence Level: Guideline reference or evidence grade (e.g., "Level 1, FDA approved") 7. Expected Outcome: Timeline and success metrics
Design principles:
- Use small boxes/tables for organization (like the clinical treatment recommendation card format)
- Eliminate all non-essential text
- Use abbreviations familiar to clinicians
- Dense information layout - maximize information per square inch
- Think "quick reference card" not "comprehensive documentation"
Example structure:
[Patient ID/Diagnosis Box at top]
TARGET PATIENT POPULATION
Number of patients, demographics, key features
PRIMARY TREATMENT REGIMEN
• Medication 1: dose, frequency, duration
• Procedure: specific details
• Monitoring: what and when
SUPPORTIVE CARE
• Key supportive medications
RATIONALE
Brief clinical justification
MOLECULAR TARGETS / RISK FACTORS
Relevant biomarkers or risk stratification
EVIDENCE LEVEL
Guideline reference, trial data
MONITORING REQUIREMENTS
Key labs/vitals, frequency
EXPECTED CLINICAL BENEFIT
Primary endpoint, timelineOption 2: Standard 3-4 Page Format
When to use: Moderate complexity, need for patient education materials, multidisciplinary coordination
Uses the Foundation Medicine first-page summary model with 2-3 additional pages of details.
Option 3: Extended 5-6 Page Format
When to use: Complex comorbidities, research protocols, extensive safety monitoring required
First Page Summary (Foundation Medicine Model)
CRITICAL REQUIREMENT: All treatment plans MUST have a complete executive summary on the first page ONLY, before any table of contents or detailed sections.
Following the Foundation Medicine model for precision medicine reporting and clinical summary documents, treatment plans begin with a one-page executive summary that provides immediate access to key actionable information. This entire summary must fit on the first page.
Required First Page Structure (in order):
1. Title and Subtitle
- Main title: Treatment plan type (e.g., "Comprehensive Treatment Plan")
- Subtitle: Specific condition or focus (e.g., "Type 2 Diabetes Mellitus - Young Adult Patient")
2. Report Information Box (using \begin{infobox} or \begin{patientinfo})
- Report type/document purpose
- Date of plan creation
- Patient demographics (age, sex, de-identified)
- Primary diagnosis with ICD-10 code
- Report author/clinic (if applicable)
- Analysis approach or framework used
3. Key Findings or Treatment Highlights (2-4 colored boxes using appropriate box types)
- Primary Treatment Goals (using
\begin{goalbox}) - 2-3 SMART goals in bullet format
- Main Interventions (using
\begin{keybox}or\begin{infobox}) - 2-3 key interventions (pharmacological, non-pharmacological, monitoring)
- Critical Decision Points (using
\begin{warningbox}if urgent) - Important monitoring thresholds or safety considerations
- Timeline Overview (using
\begin{infobox}) - Brief treatment duration/phases
- Key milestone dates
Visual Format Requirements:
- Use
\thispagestyle{empty}to remove page numbers from first page - All content must fit on page 1 (before
\newpage) - Use colored boxes (tcolorbox package) with different colors for different information types
- Boxes should be visually prominent and easy to scan
- Use concise, bullet-point format
- Table of contents (if included) starts on page 2
- Detailed sections start on page 3
Example First Page Structure:
\maketitle
\thispagestyle{empty}
% Report Information Box
\begin{patientinfo}
Report Type, Date, Patient Info, Diagnosis, etc.
\end{patientinfo}
% Key Finding #1: Treatment Goals
\begin{goalbox}[Primary Treatment Goals]
• Goal 1
• Goal 2
• Goal 3
\end{goalbox}
% Key Finding #2: Main Interventions
\begin{keybox}[Core Interventions]
• Intervention 1
• Intervention 2
• Intervention 3
\end{keybox}
% Key Finding #3: Critical Monitoring (if applicable)
\begin{warningbox}[Critical Decision Points]
• Decision point 1
• Decision point 2
\end{warningbox}
\newpage
\tableofcontents % TOC on page 2
\newpage % Detailed content starts page 3Concise Documentation
CRITICAL: Treatment plans MUST prioritize brevity and clinical relevance. Default to 3-4 pages maximum unless clinical complexity absolutely demands more detail.
Treatment plans should prioritize clarity and actionability over exhaustive detail:
- Focused: Include only clinically essential information that impacts care decisions
- Actionable: Emphasize what needs to be done, when, and why
- Efficient: Facilitate quick decision-making without sacrificing clinical quality
- Target length options:
- 1-page format (preferred for straightforward cases): Quick-reference card with all essential information
- 3-4 pages standard: Standard format with first-page summary + supporting details
- 5-6 pages (rare): Only for highly complex cases with multiple comorbidities or multidisciplinary interventions
Streamlining Guidelines:
- First Page Summary: Use individual colored boxes to consolidate key information (goals, interventions, decision points) - this alone can often convey the essential treatment plan
- Eliminate Redundancy: If information is in the first-page summary, don't repeat it verbatim in detailed sections
- Patient Education section: 3-5 key bullet points on critical topics and warning signs only
- Risk Mitigation section: Highlight only critical medication safety concerns and emergency actions (not exhaustive lists)
- Expected Outcomes section: 2-3 concise statements on anticipated responses and timelines
- Interventions: Focus on primary interventions; secondary/supportive measures in brief bullet format
- Use tables and bullet points extensively for efficient presentation
- Avoid narrative prose where structured lists suffice
- Combine related sections when appropriate to reduce page count
Quality Over Quantity
The goal is professional, clinically complete documentation that respects clinicians' time while ensuring comprehensive patient care. Every section should add value; remove or condense sections that don't directly inform treatment decisions.
Citations and Evidence Support
Use minimal, targeted citations to support clinical recommendations:
- Text Citations Preferred: Use brief in-text citations (Author Year) or simple references rather than extensive bibliographies unless specifically requested
- When to Cite:
- Clinical practice guideline recommendations (e.g., "per ADA 2024 guidelines")
- Specific medication dosing or protocols (e.g., "ACC/AHA recommendations")
- Novel or controversial interventions requiring evidence support
- Risk stratification tools or validated assessment scales
- When NOT to Cite:
- Standard-of-care interventions widely accepted in the field
- Basic medical facts and routine clinical practices
- General patient education content
- Citation Format:
- Inline: "Initiate metformin as first-line therapy (ADA Standards of Care 2024)"
- Minimal: "Treatment follows ACC/AHA heart failure guidelines"
- Avoid formal numbered references and extensive bibliography sections unless document is for academic/research purposes
- Keep it Brief: A 3-4 page treatment plan should have 0-3 citations maximum, only where essential for clinical credibility or novel recommendations
Core Capabilities
1. General Medical Treatment Plans
General medical treatment plans address common chronic conditions and acute medical issues requiring structured therapeutic interventions.
Standard Components
Patient Information (De-identified)
- Demographics (age, sex, relevant medical background)
- Active medical conditions and comorbidities
- Current medications and allergies
- Relevant social and family history
- Functional status and baseline assessments
- HIPAA Compliance: Remove all 18 identifiers per Safe Harbor method
Diagnosis and Assessment Summary
- Primary diagnosis with ICD-10 code
- Secondary diagnoses and comorbidities
- Severity classification and staging
- Functional limitations and quality of life impact
- Risk stratification (e.g., cardiovascular risk, fall risk)
- Prognostic indicators
Treatment Goals (SMART Format)
Short-term goals (1-3 months):
- Specific: Clearly defined outcome (e.g., "Reduce HbA1c to <7%")
- Measurable: Quantifiable metrics (e.g., "Decrease systolic BP by 10 mmHg")
- Achievable: Realistic given patient capabilities
- Relevant: Aligned with patient priorities and values
- Time-bound: Specific timeframe (e.g., "within 8 weeks")
Long-term goals (6-12 months):
- Disease control or remission targets
- Functional improvement objectives
- Quality of life enhancement
- Prevention of complications
- Maintenance of independence
Interventions
Pharmacological:
- Medications with specific dosages, routes, frequencies
- Titration schedules and target doses
- Drug-drug interaction considerations
- Monitoring for adverse effects
- Medication reconciliation
Non-pharmacological:
- Lifestyle modifications (diet, exercise, smoking cessation)
- Behavioral interventions
- Patient education and self-management
- Monitoring and self-tracking (glucose, blood pressure, weight)
- Assistive devices or adaptive equipment
Procedural:
- Planned procedures or interventions
- Referrals to specialists
- Diagnostic testing schedule
- Preventive care (vaccinations, screenings)
Timeline and Schedule
- Treatment phases with specific timeframes
- Appointment frequency (weekly, monthly, quarterly)
- Milestone assessments and goal evaluations
- Medication adjustments schedule
- Expected duration of treatment
Monitoring Parameters
- Clinical outcomes to track (vital signs, lab values, symptoms)
- Assessment tools and scales (e.g., PHQ-9, pain scales)
- Frequency of monitoring
- Thresholds for intervention or escalation
- Patient-reported outcomes
Expected Outcomes
- Primary outcome measures
- Success criteria and benchmarks
- Expected timeline for improvement
- Criteria for treatment modification
- Long-term prognosis
Follow-up Plan
- Scheduled appointments and reassessments
- Communication plan (phone calls, secure messaging)
- Emergency contact procedures
- Criteria for urgent evaluation
- Transition or discharge planning
Patient Education
- Understanding of condition and treatment rationale
- Self-management skills training
- Medication administration and adherence
- Warning signs and when to seek help
- Resources and support services
Risk Mitigation
- Potential adverse effects and management
- Drug interactions and contraindications
- Fall prevention, infection prevention
- Emergency action plans
- Safety monitoring
Common Applications
- Diabetes mellitus management
- Hypertension control
- Heart failure treatment
- COPD management
- Asthma care plans
- Hyperlipidemia treatment
- Osteoarthritis management
- Chronic kidney disease
2. Rehabilitation Treatment Plans
Rehabilitation plans focus on restoring function, improving mobility, and enhancing quality of life through structured therapeutic programs.
Core Components
Functional Assessment
- Baseline functional status (ADLs, IADLs)
- Range of motion, strength, balance, endurance
- Gait analysis and mobility assessment
- Standardized measures (FIM, Barthel Index, Berg Balance Scale)
- Environmental assessment (home safety, accessibility)
Rehabilitation Goals
Impairment-level goals:
- Improve shoulder flexion to 140 degrees
- Increase quadriceps strength by 2/5 MMT grades
- Enhance balance (Berg Score >45/56)
Activity-level goals:
- Independent ambulation 150 feet with assistive device
- Climb 12 stairs with handrail supervision
- Transfer bed-to-chair independently
Participation-level goals:
- Return to work with modifications
- Resume recreational activities
- Independent community mobility
Therapeutic Interventions
Physical Therapy:
- Therapeutic exercises (strengthening, stretching, endurance)
- Manual therapy techniques
- Gait training and balance activities
- Modalities (heat, ice, electrical stimulation, ultrasound)
- Assistive device training
Occupational Therapy:
- ADL training (bathing, dressing, grooming, feeding)
- Upper extremity strengthening and coordination
- Adaptive equipment and modifications
- Energy conservation techniques
- Cognitive rehabilitation
Speech-Language Pathology:
- Swallowing therapy and dysphagia management
- Communication strategies and augmentative devices
- Cognitive-linguistic therapy
- Voice therapy
Other Services:
- Recreational therapy
- Aquatic therapy
- Cardiac rehabilitation
- Pulmonary rehabilitation
- Vestibular rehabilitation
Treatment Schedule
- Frequency: 3x/week PT, 2x/week OT (example)
- Session duration: 45-60 minutes
- Treatment phase durations (acute, subacute, maintenance)
- Expected total duration: 8-12 weeks
- Reassessment intervals
Progress Monitoring
- Weekly functional assessments
- Standardized outcome measures
- Goal attainment scaling
- Pain and symptom tracking
- Patient satisfaction
Home Exercise Program
- Specific exercises with repetitions/sets/frequency
- Precautions and safety instructions
- Progression criteria
- Self-monitoring strategies
Specialty Rehabilitation
- Post-stroke rehabilitation
- Orthopedic rehabilitation (joint replacement, fracture)
- Cardiac rehabilitation (post-MI, post-surgery)
- Pulmonary rehabilitation
- Vestibular rehabilitation
- Neurological rehabilitation
- Sports injury rehabilitation
3. Mental Health Treatment Plans
Mental health treatment plans address psychiatric conditions through integrated psychotherapeutic, pharmacological, and psychosocial interventions.
Essential Components
Psychiatric Assessment
- Primary psychiatric diagnosis (DSM-5 criteria)
- Symptom severity and functional impairment
- Co-occurring mental health conditions
- Substance use assessment
- Suicide/homicide risk assessment
- Trauma history and PTSD screening
- Social determinants of mental health
Treatment Goals
Symptom reduction:
- Decrease depression severity (PHQ-9 score from 18 to <10)
- Reduce anxiety symptoms (GAD-7 score <5)
- Improve sleep quality (Pittsburgh Sleep Quality Index)
- Stabilize mood (reduced mood episodes)
Functional improvement:
- Return to work or school
- Improve social relationships and support
- Enhance coping skills and emotional regulation
- Increase engagement in meaningful activities
Recovery-oriented goals:
- Build resilience and self-efficacy
- Develop crisis management skills
- Establish sustainable wellness routines
- Achieve personal recovery goals
Therapeutic Interventions
Psychotherapy:
- Evidence-based modality (CBT, DBT, ACT, psychodynamic, IPT)
- Session frequency (weekly, biweekly)
- Treatment duration (12-16 weeks, ongoing)
- Specific techniques and targets
- Group therapy participation
Psychopharmacology:
- Medication class and rationale
- Starting dose and titration schedule
- Target symptoms
- Expected response timeline (2-4 weeks for antidepressants)
- Side effect monitoring
- Combination therapy considerations
Psychosocial Interventions:
- Case management services
- Peer support programs
- Family therapy or psychoeducation
- Vocational rehabilitation
- Supported housing or community integration
- Substance abuse treatment
Safety Planning
- Crisis contacts and emergency services
- Warning signs and triggers
- Coping strategies and self-soothing techniques
- Safe environment modifications
- Means restriction (firearms, medications)
- Support system activation
Monitoring and Assessment
- Symptom rating scales (weekly or biweekly)
- Medication adherence and side effects
- Suicidal ideation screening
- Functional status assessments
- Treatment engagement and therapeutic alliance
Patient and Family Education
- Psychoeducation about diagnosis
- Treatment rationale and expectations
- Medication information
- Relapse prevention strategies
- Community resources
Mental Health Conditions
- Major depressive disorder
- Anxiety disorders (GAD, panic, social anxiety)
- Bipolar disorder
- Schizophrenia and psychotic disorders
- PTSD and trauma-related disorders
- Eating disorders
- Substance use disorders
- Personality disorders
4. Chronic Disease Management Plans
Comprehensive long-term care plans for chronic conditions requiring ongoing monitoring, treatment adjustments, and multidisciplinary coordination.
Key Features
Disease-Specific Targets
- Evidence-based treatment goals per guidelines
- Stage-appropriate interventions
- Complication prevention strategies
- Disease progression monitoring
Self-Management Support
- Patient activation and engagement
- Shared decision-making
- Action plans for symptom changes
- Technology-enabled monitoring (apps, remote monitoring)
Care Coordination
- Primary care physician oversight
- Specialist consultations and co-management
- Care transitions (hospital to home)
- Medication management across providers
- Communication protocols
Population Health Integration
- Registry tracking and outreach
- Preventive care and screening schedules
- Quality measure reporting
- Care gaps identification
Applicable Conditions
- Type 1 and Type 2 diabetes
- Cardiovascular disease (CHF, CAD)
- Chronic respiratory diseases (COPD, asthma)
- Chronic kidney disease
- Inflammatory bowel disease
- Rheumatoid arthritis and autoimmune conditions
- HIV/AIDS
- Cancer survivorship care
5. Perioperative Care Plans
Structured plans for surgical and procedural patients covering preoperative preparation, intraoperative management, and postoperative recovery.
Components
Preoperative Assessment
- Surgical indication and planned procedure
- Preoperative risk stratification (ASA class, cardiac risk)
- Optimization of medical conditions
- Medication management (continuation, discontinuation)
- Preoperative testing and clearances
- Informed consent and patient education
Perioperative Interventions
- Enhanced recovery after surgery (ERAS) protocols
- Venous thromboembolism prophylaxis
- Antibiotic prophylaxis
- Glycemic control strategies
- Pain management plan (multimodal analgesia)
Postoperative Care
- Immediate recovery goals (24-48 hours)
- Early mobilization protocols
- Diet advancement
- Wound care and drain management
- Pain control regimen
- Complication monitoring
Discharge Planning
- Activity restrictions and progression
- Medication reconciliation
- Follow-up appointments
- Home health or rehabilitation services
- Return-to-work timeline
6. Pain Management Plans
Multimodal approaches to acute and chronic pain using evidence-based interventions and opioid-sparing strategies.
Comprehensive Components
Pain Assessment
- Pain location, quality, intensity (0-10 scale)
- Temporal pattern (constant, intermittent, breakthrough)
- Aggravating and alleviating factors
- Functional impact (sleep, activities, mood)
- Previous treatments and responses
- Psychosocial contributors
Multimodal Interventions
Pharmacological:
- Non-opioid analgesics (acetaminophen, NSAIDs)
- Adjuvant medications (antidepressants, anticonvulsants, muscle relaxants)
- Topical agents (lidocaine, capsaicin, diclofenac)
- Opioid therapy (when appropriate, with risk mitigation)
- Titration and rotation strategies
Interventional Procedures:
- Nerve blocks and injections
- Radiofrequency ablation
- Spinal cord stimulation
- Intrathecal drug delivery
Non-pharmacological:
- Physical therapy and exercise
- Cognitive-behavioral therapy for pain
- Mindfulness and relaxation techniques
- Acupuncture
- TENS units
Opioid Safety (when prescribed)
- Indication and planned duration
- Prescription drug monitoring program (PDMP) check
- Opioid risk assessment tools
- Naloxone prescription
- Treatment agreements
- Random urine drug screening
- Frequent follow-up and reassessment
Functional Goals
- Specific activity improvements
- Sleep quality enhancement
- Reduced pain interference
- Improved quality of life
- Return to work or meaningful activities
Best Practices
Brevity and Focus (HIGHEST PRIORITY)
Treatment plans MUST be concise and focused on actionable clinical information:
- 1-page format is PREFERRED: For most clinical scenarios, a single-page treatment plan (like precision oncology reports) provides all necessary information
- Default to shortest format possible: Start with 1-page; only expand if clinical complexity genuinely requires it
- Every sentence must add value: If a section doesn't change clinical decision-making, omit it entirely
- Think "quick reference card" not "comprehensive textbook": Busy clinicians need scannable, dense information
- Avoid academic verbosity: This is clinical documentation, not a literature review or teaching document
- Maximum lengths by complexity:
- Simple/standard cases: 1 page
- Moderate complexity: 3-4 pages (first-page summary + details)
- High complexity (rare): 5-6 pages maximum
First Page Summary (Most Important)
ALWAYS create a one-page executive summary as the first page:
- The first page must contain ONLY: Title, Report Info Box, and Key Findings boxes
- This provides an at-a-glance overview similar to precision medicine reports
- Table of contents and detailed sections start on page 2 or later
- Think of it as a "clinical highlights" page that a busy clinician can scan in 30 seconds
- Use 2-4 colored boxes for different key findings (goals, interventions, decision points)
- A strong first page can often stand alone - subsequent pages are for details, not repetition
SMART Goal Setting
All treatment goals should meet SMART criteria:
- Specific: "Improve HbA1c to <7%" not "Better diabetes control"
- Measurable: Use quantifiable metrics, validated scales, objective measures
- Achievable: Consider patient capabilities, resources, social support
- Relevant: Align with patient values, priorities, and life circumstances
- Time-bound: Define clear timeframes for goal achievement and reassessment
Patient-Centered Care
✓ Shared Decision-Making: Involve patients in goal-setting and treatment choices ✓ Cultural Competence: Respect cultural beliefs, language preferences, health literacy ✓ Patient Preferences: Honor treatment preferences and personal values ✓ Individualization: Tailor plans to patient's unique circumstances ✓ Empowerment: Support patient activation and self-management
Evidence-Based Practice
✓ Clinical Guidelines: Follow current specialty society recommendations ✓ Quality Measures: Incorporate HEDIS, CMS quality measures ✓ Comparative Effectiveness: Use treatments with proven efficacy ✓ Avoid Low-Value Care: Eliminate unnecessary tests and interventions ✓ Stay Current: Update plans based on emerging evidence
Documentation Standards
✓ Completeness: Include all required elements ✓ Clarity: Use clear, professional medical language ✓ Accuracy: Ensure factual correctness and current information ✓ Timeliness: Document plans promptly ✓ Legibility: Professional formatting and organization ✓ Signature and Date: Authenticate all treatment plans
Regulatory Compliance
✓ HIPAA Privacy: De-identify all protected health information ✓ Informed Consent: Document patient understanding and agreement ✓ Billing Support: Include documentation to support medical necessity ✓ Quality Reporting: Enable extraction of quality metrics ✓ Legal Protection: Maintain defensible clinical documentation
Multidisciplinary Coordination
✓ Team Communication: Share plans across care team ✓ Role Clarity: Define responsibilities for each team member ✓ Care Transitions: Ensure continuity across settings ✓ Specialist Integration: Coordinate with subspecialty care ✓ Patient-Centered Medical Home: Align with PCMH principles
LaTeX Template Usage
Template Selection
Choose the appropriate template based on clinical context and desired length:
Concise Templates (PREFERRED)
1. one_page_treatment_plan.tex - FIRST CHOICE for most cases
- All clinical specialties
- Standard protocols and straightforward cases
- Quick-reference format similar to precision oncology reports
- Dense, scannable, clinician-focused
- Use this unless complexity demands more detail
Standard Templates (3-4 pages)
Use only when one-page format is insufficient due to complexity:
2. general_medical_treatment_plan.tex - Primary care, chronic disease, general medicine 3. rehabilitation_treatment_plan.tex - PT/OT, post-surgery, injury recovery 4. mental_health_treatment_plan.tex - Psychiatric conditions, behavioral health 5. chronic_disease_management_plan.tex - Complex chronic diseases, multiple conditions 6. perioperative_care_plan.tex - Surgical patients, procedural care 7. pain_management_plan.tex - Acute or chronic pain conditions
Note: Even when using standard templates, adapt them to be concise (3-4 pages max) by removing non-essential sections.
Template Structure
All LaTeX templates include:
- Professional formatting with appropriate margins and fonts
- Structured sections for all required components
- Tables for medications, interventions, timelines
- Goal-tracking sections with SMART criteria
- Space for provider signatures and dates
- HIPAA-compliant de-identification guidance
- Comments with detailed instructions
Generating PDFs
# Compile LaTeX template to PDF
pdflatex general_medical_treatment_plan.tex
# For templates with references
pdflatex treatment_plan.tex
bibtex treatment_plan
pdflatex treatment_plan.tex
pdflatex treatment_plan.texValidation and Quality Assurance
Completeness Checking
Use validation scripts to ensure all required sections are present:
python check_completeness.py my_treatment_plan.texThe script checks for:
- Patient information section
- Diagnosis and assessment
- SMART goals (short-term and long-term)
- Interventions (pharmacological, non-pharmacological)
- Timeline and schedule
- Monitoring parameters
- Expected outcomes
- Follow-up plan
- Patient education
- Risk mitigation
Treatment Plan Validation
Comprehensive validation of treatment plan quality:
python validate_treatment_plan.py my_treatment_plan.texValidation includes:
- SMART goal criteria assessment
- Evidence-based intervention verification
- Timeline feasibility check
- Monitoring parameter adequacy
- Safety and risk mitigation review
- Regulatory compliance check
Quality Checklist
Review treatment plans against the quality checklist (quality_checklist.md):
Clinical Quality
- [ ] Diagnosis is accurate and properly coded (ICD-10)
- [ ] Goals are SMART and patient-centered
- [ ] Interventions are evidence-based and guideline-concordant
- [ ] Timeline is realistic and clearly defined
- [ ] Monitoring plan is comprehensive
- [ ] Safety considerations are addressed
Patient-Centered Care
- [ ] Patient preferences and values incorporated
- [ ] Shared decision-making documented
- [ ] Health literacy appropriate language
- [ ] Cultural considerations addressed
- [ ] Patient education plan included
Regulatory Compliance
- [ ] HIPAA-compliant de-identification
- [ ] Medical necessity documented
- [ ] Informed consent noted
- [ ] Provider signature and credentials
- [ ] Date of plan creation/revision
Coordination and Communication
- [ ] Specialist referrals documented
- [ ] Care team roles defined
- [ ] Follow-up schedule clear
- [ ] Emergency contacts provided
- [ ] Transition planning addressed
Integration with Other Skills
Clinical Reports Integration
Treatment plans often accompany other clinical documentation:
- SOAP Notes (
clinical-reportsskill): Document ongoing implementation - H&P (
clinical-reportsskill): Initial assessment informs treatment plan - Discharge Summaries (
clinical-reportsskill): Summarize treatment plan execution - Progress Notes: Track goal achievement and plan modifications
Scientific Writing Integration
Evidence-based treatment planning requires literature support:
- Citation Management (
citation-managementskill): Reference clinical guidelines - Literature Review (
literature-reviewskill): Understand treatment evidence base - Research Lookup (
research-lookupskill): Find current best practices
Research Integration
Treatment plans may be developed for clinical trials or research studies:
- Research Grants (
research-grantsskill): Treatment protocols for funded studies - Clinical Trial Reports (
clinical-reportsskill): Intervention documentation
Common Use Cases
Example 1: Type 2 Diabetes Management
Scenario: 58-year-old patient with newly diagnosed Type 2 diabetes, HbA1c 8.5%, BMI 32
Template: general_medical_treatment_plan.tex
Goals:
- Short-term: Reduce HbA1c to <7.5% in 3 months
- Long-term: Achieve HbA1c <7%, lose 15 pounds in 6 months
Interventions:
- Pharmacological: Metformin 500mg BID, titrate to 1000mg BID
- Lifestyle: Mediterranean diet, 150 min/week moderate exercise
- Education: Diabetes self-management education, glucose monitoring
Example 2: Post-Stroke Rehabilitation
Scenario: 70-year-old patient s/p left MCA stroke with right hemiparesis
Template: rehabilitation_treatment_plan.tex
Goals:
- Short-term: Improve right arm strength 2/5 to 3/5 in 4 weeks
- Long-term: Independent ambulation 150 feet with cane in 12 weeks
Interventions:
- PT 3x/week: Gait training, balance, strengthening
- OT 3x/week: ADL training, upper extremity function
- SLP 2x/week: Dysphagia therapy
Example 3: Major Depressive Disorder
Scenario: 35-year-old with moderate depression, PHQ-9 score 16
Template: mental_health_treatment_plan.tex
Goals:
- Short-term: Reduce PHQ-9 to <10 in 8 weeks
- Long-term: Achieve remission (PHQ-9 <5), return to work
Interventions:
- Psychotherapy: CBT weekly sessions
- Medication: Sertraline 50mg daily, titrate to 100mg
- Lifestyle: Sleep hygiene, exercise 30 min 5x/week
Example 4: Total Knee Arthroplasty
Scenario: 68-year-old scheduled for right TKA for osteoarthritis
Template: perioperative_care_plan.tex
Preoperative Goals:
- Optimize diabetes control (glucose <180)
- Discontinue anticoagulation per protocol
- Complete medical clearance
Postoperative Goals:
- Ambulate 50 feet by POD 1
- 90-degree knee flexion by POD 3
- Discharge home with PT services by POD 2-3
Example 5: Chronic Low Back Pain
Scenario: 45-year-old with chronic non-specific low back pain, pain 7/10
Template: pain_management_plan.tex
Goals:
- Short-term: Reduce pain to 4/10 in 6 weeks
- Long-term: Return to work full-time, pain 2-3/10
Interventions:
- Pharmacological: Gabapentin 300mg TID, duloxetine 60mg daily
- PT: Core strengthening, McKenzie exercises 2x/week x 8 weeks
- Behavioral: CBT for pain, mindfulness meditation
- Interventional: Consider lumbar ESI if inadequate response
Professional Standards and Guidelines
Treatment plans should align with:
General Medicine
- American Diabetes Association (ADA) Standards of Care
- ACC/AHA Cardiovascular Guidelines
- GOLD COPD Guidelines
- JNC-8 Hypertension Guidelines
- KDIGO Chronic Kidney Disease Guidelines
Rehabilitation
- APTA Clinical Practice Guidelines
- AOTA Practice Guidelines
- Cardiac Rehabilitation Guidelines (AHA/AACVPR)
- Stroke Rehabilitation Guidelines
Mental Health
- APA Practice Guidelines
- VA/DoD Clinical Practice Guidelines
- NICE Guidelines (National Institute for Health and Care Excellence)
- Cochrane Reviews for psychiatric interventions
Pain Management
- CDC Opioid Prescribing Guidelines
- AAPM/APS Chronic Pain Guidelines
- WHO Pain Ladder
- Multimodal Analgesia Best Practices
Timeline Generation
Use the timeline generator script to create visual treatment timelines:
python timeline_generator.py --plan my_treatment_plan.tex --output timeline.pdfGenerates:
- Gantt chart of treatment phases
- Milestone markers for goal assessments
- Medication titration schedules
- Follow-up appointment calendar
- Intervention intensity over time
Support and Resources
Template Generation
Interactive template selection:
cd .claude/skills/treatment-plans/scripts
python generate_template.py
# Or specify type directly
python generate_template.py --type mental_health --output depression_treatment_plan.texValidation Workflow
1. Create treatment plan using appropriate LaTeX template 2. Check completeness: python check_completeness.py plan.tex 3. Validate quality: python validate_treatment_plan.py plan.tex 4. Review checklist: Compare against quality_checklist.md 5. Generate PDF: pdflatex plan.tex 6. Review with patient: Ensure understanding and agreement 7. Implement and document: Track progress in clinical notes
Additional Resources
- Clinical practice guidelines from specialty societies
- AHRQ Effective Health Care Program
- Cochrane Library for intervention evidence
- UpToDate and DynaMed for treatment recommendations
- CMS Quality Measures and HEDIS specifications
Professional Document Styling
Overview
Treatment plans can be enhanced with professional medical document styling using the medical_treatment_plan.sty LaTeX package. This custom style transforms plain academic documents into visually appealing, color-coded clinical documents that maintain scientific rigor while improving readability and usability.
Medical Treatment Plan Style Package
The medical_treatment_plan.sty package (located in assets/medical_treatment_plan.sty) provides:
Professional Color Scheme
- Primary Blue (RGB: 0, 102, 153): Headers, section titles, primary accents
- Secondary Blue (RGB: 102, 178, 204): Light backgrounds, subtle accents
- Accent Blue (RGB: 0, 153, 204): Hyperlinks, key highlights
- Success Green (RGB: 0, 153, 76): Goals, positive outcomes
- Warning Red (RGB: 204, 0, 0): Warnings, critical information
- Dark Gray (RGB: 64, 64, 64): Body text
- Light Gray (RGB: 245, 245, 245): Background fills
Styled Elements
- Custom colored headers and footers with professional rules
- Blue section titles with underlines for clear hierarchy
- Enhanced table formatting with colored headers and alternating rows
- Optimized list spacing with colored bullets and numbering
- Professional page layout with appropriate margins
Custom Information Boxes
The style package includes five specialized box environments for organizing clinical information:
1. Info Box (Blue Border, Light Gray Background)
For general information, clinical assessments, and testing schedules:
\begin{infobox}[Title]
\textbf{Key Information:}
\begin{itemize}
\item Clinical assessment details
\item Testing schedules
\item General guidance
\end{itemize}
\end{infobox}Use cases: Metabolic status, baseline assessments, monitoring schedules, titration protocols
2. Warning Box (Red Border, Yellow Background)
For critical decision points, safety protocols, and alerts:
\begin{warningbox}[Alert Title]
\textbf{Important Safety Information:}
\begin{itemize}
\item Critical drug interactions
\item Safety monitoring requirements
\item Red flag symptoms requiring immediate action
\end{itemize}
\end{warningbox}Use cases: Medication safety, decision points, contraindications, emergency protocols
3. Goal Box (Green Border, Green-Tinted Background)
For treatment goals, targets, and success criteria:
\begin{goalbox}[Treatment Goals]
\textbf{Primary Objectives:}
\begin{itemize}
\item Reduce HbA1c to <7\% within 3 months
\item Achieve 5-7\% weight loss in 12 weeks
\item Complete diabetes education program
\end{itemize}
\end{goalbox}Use cases: SMART goals, target outcomes, success metrics, CGM goals
4. Key Points Box (Blue Background)
For executive summaries, key takeaways, and important recommendations:
\begin{keybox}[Key Highlights]
\textbf{Essential Points:}
\begin{itemize}
\item Main therapeutic approach
\item Critical patient instructions
\item Priority interventions
\end{itemize}
\end{keybox}Use cases: Plan overview, plate method instructions, important dietary guidelines
5. Emergency Box (Large Red Design)
For emergency contacts and urgent protocols:
\begin{emergencybox}
\begin{itemize}
\item \textbf{Emergency Services:} 911
\item \textbf{Endocrinology Office:} [Phone] (business hours)
\item \textbf{After-Hours Hotline:} [Phone] (nights/weekends)
\item \textbf{Pharmacy:} [Phone and location]
\end{itemize}
\end{emergencybox}Use cases: Emergency contacts, critical hotlines, urgent resource information
6. Patient Info Box (White with Blue Border)
For patient demographics and baseline information:
\begin{patientinfo}
\begin{tabular}{ll}
\textbf{Age:} & 23 years \\
\textbf{Sex:} & Male \\
\textbf{Diagnosis:} & Type 2 Diabetes Mellitus \\
\textbf{Plan Start Date:} & \today \\
\end{tabular}
\end{patientinfo}Use cases: Patient information sections, demographic data
Professional Table Formatting
Enhanced table environment with medical styling:
\begin{medtable}{Caption Text}
\begin{tabular}{|p{5cm}|p{4cm}|p{4.5cm}|}
\hline
\tableheadercolor % Blue header with white text
\textcolor{white}{\textbf{Column 1}} &
\textcolor{white}{\textbf{Column 2}} &
\textcolor{white}{\textbf{Column 3}} \\
\hline
Data row 1 content & Value 1 & Details 1 \\
\hline
\tablerowcolor % Alternating light gray row
Data row 2 content & Value 2 & Details 2 \\
\hline
Data row 3 content & Value 3 & Details 3 \\
\hline
\end{tabular}
\caption{Table caption}
\end{medtable}Features:
- Blue headers with white text for visual prominence
- Alternating row colors (
\tablerowcolor) for improved readability - Automatic centering and spacing
- Professional borders and padding
Using the Style Package
Basic Setup
1. Add to document preamble:
% !TEX program = xelatex
\documentclass[11pt,letterpaper]{article}
% Use custom medical treatment plan style
\usepackage{medical_treatment_plan}
\usepackage{natbib}
\begin{document}
\maketitle
% Your content here
\end{document}2. Ensure style file is in same directory as your .tex file, or install to LaTeX path
3. Compile with XeLaTeX (recommended for best results):
xelatex treatment_plan.tex
bibtex treatment_plan
xelatex treatment_plan.tex
xelatex treatment_plan.texCustom Title Page
The package automatically formats the title with a professional blue header:
\title{\textbf{Individualized Diabetes Treatment Plan}\\
\large{23-Year-Old Male Patient with Type 2 Diabetes}}
\author{Comprehensive Care Plan}
\date{\today}
\begin{document}
\maketitleThis creates an eye-catching blue box with white text and clear hierarchy.
Compilation Requirements
Required LaTeX Packages (automatically loaded by the style):
geometry- Page layout and marginsxcolor- Color supporttcolorboxwith[most]library - Custom colored boxestikz- Graphics and drawingfontspec- Font management (XeLaTeX/LuaLaTeX)fancyhdr- Custom headers and footerstitlesec- Section stylingenumitem- Enhanced list formattingbooktabs- Professional table ruleslongtable- Multi-page tablesarray- Enhanced table featurescolortbl- Colored table cellshyperref- Hyperlinks and PDF metadatanatbib- Bibliography management
Recommended Compilation:
# Using XeLaTeX (best font support)
xelatex document.tex
bibtex document
xelatex document.tex
xelatex document.tex
# Using PDFLaTeX (alternative)
pdflatex document.tex
bibtex document
pdflatex document.tex
pdflatex document.texCustomization Options
Changing Colors
Edit the style file to modify the color scheme:
% In medical_treatment_plan.sty
\definecolor{primaryblue}{RGB}{0, 102, 153} % Modify these
\definecolor{secondaryblue}{RGB}{102, 178, 204}
\definecolor{accentblue}{RGB}{0, 153, 204}
\definecolor{successgreen}{RGB}{0, 153, 76}
\definecolor{warningred}{RGB}{204, 0, 0}Adjusting Page Layout
Modify geometry settings in the style file:
\RequirePackage[margin=1in, top=1.2in, bottom=1.2in]{geometry}Custom Fonts (XeLaTeX only)
Uncomment and modify in the style file:
\setmainfont{Your Preferred Font}
\setsansfont{Your Sans-Serif Font}Header/Footer Customization
Modify in the style file:
\fancyhead[L]{\color{primaryblue}\sffamily\small\textbf{Treatment Plan Title}}
\fancyhead[R]{\color{darkgray}\sffamily\small Patient Info}Style Package Download and Installation
Option 1: Copy to Project Directory
Copy assets/medical_treatment_plan.sty to the same directory as your .tex file.
Option 2: Install to User TeX Directory
# Find your local texmf directory
kpsewhich -var-value TEXMFHOME
# Copy to appropriate location (usually ~/texmf/tex/latex/)
mkdir -p ~/texmf/tex/latex/medical_treatment_plan
cp assets/medical_treatment_plan.sty ~/texmf/tex/latex/medical_treatment_plan/
# Update TeX file database
texhash ~/texmfOption 3: System-Wide Installation
# Copy to system texmf directory (requires sudo)
sudo cp assets/medical_treatment_plan.sty /usr/local/texlive/texmf-local/tex/latex/
sudo texhashAdditional Professional Styles (Optional)
Other medical/clinical document styles available from CTAN:
Journal Styles:
# Install via TeX Live Manager
tlmgr install nejm # New England Journal of Medicine
tlmgr install jama # JAMA style
tlmgr install bmj # British Medical JournalGeneral Professional Styles:
tlmgr install apa7 # APA 7th edition (health sciences)
tlmgr install IEEEtran # IEEE (medical devices/engineering)
tlmgr install springer # Springer journalsDownload from CTAN:
- Visit: https://ctan.org/
- Search for medical document classes
- Download and install per package instructions
Troubleshooting
Issue: Package not found
# Install missing packages via TeX Live Manager
sudo tlmgr update --self
sudo tlmgr install tcolorbox tikz pgfIssue: Missing characters (✓, ≥, etc.)
- Use XeLaTeX instead of PDFLaTeX
- Or replace with LaTeX commands:
$\checkmark$,$\geq$ - Requires
amssymbpackage for math symbols
Issue: Header height warnings
- Style file sets
\setlength{\headheight}{22pt} - Adjust if needed for your content
Issue: Boxes not rendering
# Ensure complete tcolorbox installation
sudo tlmgr install tcolorbox tikz pgfIssue: Font not found (XeLaTeX)
- Comment out custom font lines in .sty file
- Or install specified fonts on your system
Best Practices for Styled Documents
1. Appropriate Box Usage
- Match box type to content purpose (goals→green, warnings→yellow/red)
- Don't overuse boxes; reserve for truly important information
- Keep box content concise and focused
2. Visual Hierarchy
- Use section styling for structure
- Boxes for emphasis and organization
- Tables for comparative data
- Lists for sequential or grouped items
3. Color Consistency
- Stick to defined color scheme
- Use
\textcolor{primaryblue}{\textbf{Text}}for emphasis - Maintain consistent meaning (red=warning, green=goals)
4. White Space
- Don't overcrowd pages with boxes
- Use
\vspace{0.5cm}between major sections - Allow breathing room around colored elements
5. Professional Appearance
- Maintain readability as top priority
- Ensure sufficient contrast for accessibility
- Test print output in grayscale
- Keep styling consistent throughout document
6. Table Formatting
- Use
\tableheadercolorfor all header rows - Apply
\tablerowcolorto alternating rows in tables >3 rows - Keep column widths balanced
- Use
\small\sffamilyfor large tables
Example: Styled Treatment Plan Structure
% !TEX program = xelatex
\documentclass[11pt,letterpaper]{article}
\usepackage{medical_treatment_plan}
\usepackage{natbib}
\title{\textbf{Comprehensive Treatment Plan}\\
\large{Patient-Centered Care Strategy}}
\author{Multidisciplinary Care Team}
\date{\today}
\begin{document}
\maketitle
\section*{Patient Information}
\begin{patientinfo}
% Demographics table
\end{patientinfo}
\section{Executive Summary}
\begin{keybox}[Plan Overview]
% Key highlights
\end{keybox}
\section{Treatment Goals}
\begin{goalbox}[SMART Goals - 3 Months]
\begin{medtable}{Primary Treatment Targets}
% Goals table with colored headers
\end{medtable}
\end{goalbox}
\section{Medication Plan}
\begin{infobox}[Titration Schedule]
% Medication instructions
\end{infobox}
\begin{warningbox}[Critical Decision Point]
% Important safety information
\end{warningbox}
\section{Emergency Protocols}
\begin{emergencybox}
% Emergency contacts
\end{emergencybox}
\bibliographystyle{plainnat}
\bibliography{references}
\end{document}Benefits of Professional Styling
Clinical Practice:
- Faster information scanning during patient encounters
- Clear visual hierarchy for critical vs. routine information
- Professional appearance suitable for patient-facing documents
- Color-coded sections reduce cognitive load
Educational Use:
- Enhanced readability for teaching materials
- Visual differentiation of concept types (goals, warnings, procedures)
- Professional presentation for case discussions
- Print and digital-ready formats
Documentation Quality:
- Modern, polished appearance
- Maintains clinical accuracy while improving aesthetics
- Standardized formatting across treatment plans
- Easy to customize for institutional branding
Patient Engagement:
- More approachable than dense text documents
- Color coding helps patients identify key sections
- Professional appearance builds trust
- Clear organization facilitates understanding
Ethical Considerations
Informed Consent
All treatment plans should involve patient understanding and voluntary agreement to proposed interventions.
Cultural Sensitivity
Treatment plans must respect diverse cultural beliefs, health practices, and communication styles.
Health Equity
Consider social determinants of health, access barriers, and health disparities when developing plans.
Privacy Protection
Maintain strict HIPAA compliance; de-identify all protected health information in shared documents.
Autonomy and Beneficence
Balance medical recommendations with patient autonomy and values while promoting patient welfare.
License
Part of the Claude Scientific Writer project. See main LICENSE file.
% Chronic Disease Management Plan Template
% For long-term management of multiple chronic conditions
% Last updated: 2025
\documentclass[11pt,letterpaper]{article}
% Packages
\usepackage[top=1in,bottom=1in,left=1in,right=1in]{geometry}
\usepackage{amsmath,amssymb}
\usepackage[utf8]{inputenc}
\usepackage{graphicx}
\usepackage{array}
\usepackage{longtable}
\usepackage{booktabs}
\usepackage{enumitem}
\usepackage{xcolor}
\usepackage{fancyhdr}
\usepackage{lastpage}
\usepackage{tabularx}
\usepackage[most]{tcolorbox}
% Header and footer
\pagestyle{fancy}
\fancyhf{}
\lhead{Chronic Disease Management Plan}
\rhead{Page \thepage\ of \pageref{LastPage}}
\lfoot{Date Created: \today}
\rfoot{Confidential Patient Information}
% Title formatting
\usepackage{titlesec}
\titleformat{\section}{\large\bfseries}{\thesection}{1em}{}
\titleformat{\subsection}{\normalsize\bfseries}{\thesubsection}{1em}{}
\begin{document}
% Title
\begin{center}
{\Large\bfseries CHRONIC DISEASE MANAGEMENT PLAN}\\[0.5em]
{\large Comprehensive Long-Term Care Coordination}\\[0.5em]
\rule{\textwidth}{1pt}
\end{center}
\vspace{1em}
% ===== TREATMENT PLAN HIGHLIGHTS (Foundation Medicine Model) =====
\begin{tcolorbox}[colback=orange!5!white,colframe=orange!75!black,title=\textbf{TREATMENT PLAN HIGHLIGHTS},fonttitle=\bfseries\large]
\textbf{Key Diagnoses:} [Primary chronic conditions - e.g., Type 2 Diabetes, CHF (NYHA II), CKD Stage 3]
\vspace{0.3em}
\textbf{Primary Treatment Goals:}
\begin{itemize}[leftmargin=*,itemsep=0pt]
\item [Goal 1 - e.g., Maintain HbA1c $<$7.5\% and prevent diabetic complications]
\item [Goal 2 - e.g., Optimize heart failure management, prevent hospitalizations]
\item [Goal 3 - e.g., Slow CKD progression, maintain eGFR $>$45 mL/min]
\end{itemize}
\vspace{0.3em}
\textbf{Main Interventions:}
\begin{itemize}[leftmargin=*,itemsep=0pt]
\item \textit{Medications:} [Core regimen - e.g., Metformin, Lisinopril, Furosemide, statin therapy]
\item \textit{Lifestyle:} [Key modifications - e.g., Low-sodium diet, fluid restriction, regular exercise]
\item \textit{Monitoring:} [Essential tracking - e.g., Daily weights, BP, glucose; quarterly labs]
\end{itemize}
\vspace{0.3em}
\textbf{Timeline:} [Care model - e.g., Monthly visits initially, then quarterly; annual comprehensive review]
\end{tcolorbox}
\vspace{1em}
% ===== SECTION 1: PATIENT INFORMATION =====
\section*{1. Patient Information and Problem List}
\textbf{HIPAA Notice}: De-identify all protected health information before sharing.
\vspace{0.5em}
\begin{tabularx}{\textwidth}{|l|X|}
\hline
\textbf{Patient ID} & [De-identified code, e.g., CDM-001] \\ \hline
\textbf{Age Range} & [e.g., 60-65 years] \\ \hline
\textbf{Sex} & [Male/Female/Other] \\ \hline
\textbf{Date of Plan} & [Month/Year only] \\ \hline
\textbf{Primary Care Provider} & [Name, MD/DO, Credentials] \\ \hline
\textbf{Care Coordinator} & [Name, RN/NP/PA, if applicable] \\ \hline
\textbf{Facility/System} & [Healthcare organization] \\ \hline
\end{tabularx}
\vspace{1em}
\subsection*{Active Problem List (Prioritized)}
\begin{longtable}{|c|p{4cm}|c|p{3cm}|p{3.5cm}|}
\hline
\textbf{\#} & \textbf{Condition} & \textbf{ICD-10} & \textbf{Status} & \textbf{Specialists} \\ \hline
\endfirsthead
\hline
\textbf{\#} & \textbf{Condition} & \textbf{ICD-10} & \textbf{Status} & \textbf{Specialists} \\ \hline
\endhead
1 & Type 2 Diabetes Mellitus & E11.65 & Suboptimal control (HbA1c 8.2\%) & Endocrinology \\ \hline
2 & Chronic Heart Failure (HFrEF) & I50.22 & Stable, NYHA Class II & Cardiology \\ \hline
3 & Chronic Kidney Disease Stage 3b & N18.31 & Stable, eGFR 38 & Nephrology (as needed) \\ \hline
4 & Hypertension & I10 & Well-controlled on meds & PCP \\ \hline
5 & Hyperlipidemia & E78.5 & On statin, LDL at goal & PCP \\ \hline
6 & Obstructive Sleep Apnea & G47.33 & On CPAP, adherent & Sleep Medicine \\ \hline
7 & Obesity & E66.9 & BMI 34, stable weight & PCP, Nutrition \\ \hline
8 & Osteoarthritis, bilateral knees & M17.0 & Managed conservatively & Ortho (prn) \\ \hline
[Add rows] & & & & \\ \hline
\end{longtable}
\subsection*{Current Medication List}
\textit{Reconciled as of [Date]. Total: [X] medications}
\begin{longtable}{|p{3cm}|p{2cm}|p{1.8cm}|p{3cm}|p{3.5cm}|}
\hline
\textbf{Medication} & \textbf{Dose} & \textbf{Frequency} & \textbf{Indication} & \textbf{Prescriber} \\ \hline
\endfirsthead
\hline
\textbf{Medication} & \textbf{Dose} & \textbf{Frequency} & \textbf{Indication} & \textbf{Prescriber} \\ \hline
\endhead
Metformin ER & 1000mg & BID & Diabetes & PCP \\ \hline
Insulin glargine & 24 units & QHS & Diabetes & Endocrinology \\ \hline
Carvedilol & 12.5mg & BID & Heart failure, HTN & Cardiology \\ \hline
Lisinopril & 40mg & Daily & Heart failure, HTN, CKD protection & Cardiology \\ \hline
Furosemide & 40mg & Daily & Heart failure (diuresis) & Cardiology \\ \hline
Atorvastatin & 40mg & QHS & Hyperlipidemia, ASCVD prevention & PCP \\ \hline
Aspirin & 81mg & Daily & ASCVD prevention & PCP \\ \hline
[Continue list] & & & & \\ \hline
\end{longtable}
\subsection*{Care Team and Specialists}
\begin{itemize}[leftmargin=*]
\item \textbf{Primary Care Provider}: [Name, practice] - Coordinates overall care
\item \textbf{Cardiology}: [Name] - Heart failure management
\item \textbf{Endocrinology}: [Name] - Diabetes optimization
\item \textbf{Nephrology}: [Name if engaged] - CKD monitoring
\item \textbf{Care Coordinator/Navigator}: [Name] - Appointment coordination, patient education
\item \textbf{Pharmacist}: [Clinical pharmacist if available] - Medication reconciliation, optimization
\item \textbf{Registered Dietitian}: [Name] - Medical nutrition therapy
\item \textbf{Social Worker}: [Name if engaged] - Psychosocial support, resources
\end{itemize}
% ===== SECTION 2: DISEASE-SPECIFIC ASSESSMENTS =====
\section*{2. Disease-Specific Assessments and Status}
\subsection*{2.1 Type 2 Diabetes Mellitus}
\textbf{Current Status}: Suboptimal control
\begin{itemize}[leftmargin=*]
\item \textbf{HbA1c}: 8.2\% (target $<$7\%)
\item \textbf{Fasting Glucose}: Average 165 mg/dL (target 80-130)
\item \textbf{Time in Range}: Approximately 55\% (target $>$70\%)
\item \textbf{Hypoglycemia}: Infrequent, 1-2 episodes/month (BG 65-70)
\item \textbf{Duration}: 12 years
\item \textbf{Complications Screening}:
\begin{itemize}
\item Retinopathy: Mild NPDR, followed by ophthalmology
\item Nephropathy: CKD stage 3b, urine ACR 180 mg/g (albuminuria)
\item Neuropathy: Mild peripheral neuropathy, no foot ulcers
\item Cardiovascular: History of heart failure
\end{itemize}
\end{itemize}
\subsection*{2.2 Chronic Heart Failure (HFrEF)}
\textbf{Current Status}: Stable, NYHA Class II
\begin{itemize}[leftmargin=*]
\item \textbf{Ejection Fraction}: 35\% (reduced, HFrEF)
\item \textbf{Etiology}: Ischemic cardiomyopathy (prior MI 5 years ago)
\item \textbf{NYHA Class}: II - Slight limitation, comfortable at rest, symptoms with ordinary activity
\item \textbf{Symptoms}: Mild dyspnea on exertion, no orthopnea/PND, occasional LE edema
\item \textbf{Weight}: Stable, patient monitors daily
\item \textbf{GDMT Status}:
\begin{itemize}
\item ACE inhibitor: Lisinopril 40mg daily (at target dose)
\item Beta-blocker: Carvedilol 12.5mg BID (target 25mg BID - limited by fatigue)
\item Diuretic: Furosemide 40mg daily
\item Need to consider: SGLT2 inhibitor (also beneficial for diabetes), ARNI
\end{itemize}
\item \textbf{Device Therapy}: No ICD/CRT currently, discussed with cardiology
\end{itemize}
\subsection*{2.3 Chronic Kidney Disease Stage 3b}
\textbf{Current Status}: Stable
\begin{itemize}[leftmargin=*]
\item \textbf{eGFR}: 38 mL/min/1.73m² (Stage 3b, moderate-severe decrease)
\item \textbf{Creatinine}: 1.8 mg/dL (stable)
\item \textbf{Urine Albumin}: ACR 180 mg/g (albuminuria, from diabetes)
\item \textbf{Etiology}: Diabetic nephropathy, hypertensive nephropathy
\item \textbf{Progression Risk}: Moderate-high (diabetes, albuminuria)
\item \textbf{Complications}: Anemia (Hgb 11.2), managed with iron supplementation
\item \textbf{Renal Protection}: ACE inhibitor, BP control, glucose control, limit nephrotoxins
\end{itemize}
\subsection*{2.4 Additional Conditions Summary}
\begin{itemize}[leftmargin=*]
\item \textbf{Hypertension}: Well-controlled, average home BP 128/78 mmHg
\item \textbf{Hyperlipidemia}: LDL 65 mg/dL (at goal $<$70 for ASCVD), on statin
\item \textbf{Obstructive Sleep Apnea}: On CPAP nightly, AHI reduced from 32 to 4, good adherence
\item \textbf{Obesity}: BMI 34, weight stable, difficulty with weight loss due to HF exercise limitations
\item \textbf{Osteoarthritis}: Bilateral knee pain, managed with acetaminophen, PT, avoid NSAIDs (CKD)
\end{itemize}
% ===== SECTION 3: INTEGRATED GOALS =====
\section*{3. Integrated Treatment Goals (SMART Format)}
\subsection*{3.1 Short-Term Goals (3-6 months)}
\textbf{Diabetes Goals}:
\begin{enumerate}[leftmargin=*]
\item Reduce HbA1c from 8.2\% to $<$7.5\% within 3 months by optimizing insulin dosing and medication adherence.
\item Improve fasting glucose to 100-140 mg/dL range through medication adjustment and dietary changes within 3 months.
\item Complete annual diabetic eye exam and foot exam within 1 month.
\end{enumerate}
\textbf{Heart Failure Goals}:
\begin{enumerate}[leftmargin=*]
\item Maintain NYHA Class II status (no worsening) with daily weight monitoring and adherence to fluid/sodium restrictions.
\item Add SGLT2 inhibitor for dual diabetes and heart failure benefit within 1 month.
\item Improve exercise tolerance: Walk 15 minutes daily without dyspnea within 3 months.
\end{enumerate}
\textbf{CKD Goals}:
\begin{enumerate}[leftmargin=*]
\item Maintain eGFR stability ($\pm$5 mL/min from baseline 38) over 6 months.
\item Reduce urine albumin-to-creatinine ratio from 180 to $<$100 mg/g with BP and glucose control.
\item Avoid nephrotoxic agents (NSAIDs, contrast without prophylaxis).
\end{enumerate}
\textbf{Cross-Cutting Goals}:
\begin{enumerate}[leftmargin=*]
\item Medication adherence $>$90\% measured by refill rates and pill counts within 3 months.
\item Weight loss of 5\% body weight (10 lbs) through diet modification within 6 months.
\item Blood pressure maintenance at $<$130/80 mmHg (home average).
\end{enumerate}
\subsection*{3.2 Long-Term Goals (6-12 months)}
\begin{enumerate}[leftmargin=*]
\item \textbf{Diabetes}: Achieve HbA1c $<$7\% and prevent progression of microvascular complications.
\item \textbf{Heart Failure}: Optimize GDMT, prevent hospitalizations, maintain functional status.
\item \textbf{CKD}: Slow progression (goal: $<$2 mL/min/year eGFR decline), delay need for dialysis.
\item \textbf{Quality of Life}: Maintain independence in ADLs, engage in meaningful activities (gardening, grandchildren visits).
\item \textbf{Prevention}: Up-to-date with all preventive care (vaccinations, cancer screenings).
\item \textbf{Coordination}: Seamless care transitions, all providers aware of care plan, no conflicting treatments.
\end{enumerate}
\subsection*{3.3 Patient-Centered Priorities}
\begin{itemize}[leftmargin=*]
\item \textbf{Priority 1}: "I don't want to end up on dialysis like my brother"
\item \textbf{Priority 2}: "I want to keep up with my grandkids"
\item \textbf{Priority 3}: "I want to reduce my medications if possible" (pill burden concern)
\item \textbf{Priority 4}: "I want to avoid being hospitalized again"
\end{itemize}
% ===== SECTION 4: COMPREHENSIVE INTERVENTIONS =====
\section*{4. Comprehensive Interventions}
\subsection*{4.1 Medication Management and Optimization}
\textbf{Current Regimen Optimization}:
\begin{enumerate}[leftmargin=*]
\item \textbf{ADD: Empagliflozin (Jardiance) 10mg daily}
\begin{itemize}
\item \textit{Rationale}: SGLT2 inhibitor provides dual benefit - improves diabetes control AND reduces HF hospitalizations/mortality (EMPEROR-Reduced trial). Also slows CKD progression.
\item \textit{Monitoring}: eGFR (hold if $<$20), volume status, UTI symptoms, DKA risk (low in T2DM)
\item \textit{Expected benefit}: HbA1c reduction 0.5-0.8\%, reduced HF events 25-30\%
\end{itemize}
\item \textbf{TITRATE: Insulin glargine}
\begin{itemize}
\item \textit{Current}: 24 units QHS, fasting BG averaging 165
\item \textit{Plan}: Increase by 2 units every 3 days until fasting BG 100-130, patient to self-titrate with daily phone/portal check-ins
\item \textit{Expected dose}: Likely 30-36 units
\end{itemize}
\item \textbf{OPTIMIZE: Beta-blocker (carvedilol)}
\begin{itemize}
\item \textit{Current}: 12.5mg BID (patient reports fatigue at higher doses)
\item \textit{Plan}: Trial slow up-titration to 18.75mg BID, monitor for tolerance
\item \textit{Goal}: Target dose 25mg BID for HFrEF mortality benefit
\item \textit{Alternative}: Consider switching to different beta-blocker if intolerable
\end{itemize}
\item \textbf{CONTINUE}: ACE inhibitor (lisinopril 40mg) - at target dose
\item \textbf{CONSIDER FUTURE}: Sacubitril/valsartan (Entresto) to replace lisinopril if HF symptoms progress
\end{enumerate}
\textbf{Medication Safety}:
\begin{itemize}[leftmargin=*]
\item \textbf{Polypharmacy Review}: Current medication count [X], review quarterly for deprescribing opportunities
\item \textbf{Renal Dosing}: All medications reviewed for CKD Stage 3b, adjust as needed
\item \textbf{Drug Interactions}: Monitor K+ with ACE + diuretic, avoid NSAIDs (CKD, HF)
\item \textbf{Adherence Support}: Pill organizer, medication list wallet card, automatic refills, pharmacy synchronization
\end{itemize}
\subsection*{4.2 Lifestyle and Self-Management Interventions}
\textbf{Dietary Management}:
\begin{itemize}[leftmargin=*]
\item \textbf{Diabetes}:
\begin{itemize}
\item Carbohydrate consistency: 45-60g per meal
\item Mediterranean diet pattern
\item Limit refined sugars and processed carbohydrates
\end{itemize}
\item \textbf{Heart Failure}:
\begin{itemize}
\item Sodium restriction: $<$2000mg daily (low-sodium products, avoid processed foods)
\item Fluid restriction: 1.5-2L daily if needed for volume management
\end{itemize}
\item \textbf{CKD}:
\begin{itemize}
\item Moderate protein intake: 0.8-1.0 g/kg/day
\item Phosphorus and potassium awareness (but not severely restricted at Stage 3b)
\end{itemize}
\item \textbf{Weight Loss}: 500 kcal/day deficit for gradual weight loss
\item \textbf{Referral}: Registered dietitian for medical nutrition therapy
\end{itemize}
\textbf{Physical Activity}:
\begin{itemize}[leftmargin=*]
\item \textbf{Goal}: 150 min/week moderate activity (walking, swimming)
\item \textbf{Heart Failure Considerations}: Start with 10-15 min sessions, gradually increase, monitor symptoms
\item \textbf{Diabetes Benefits}: Improves insulin sensitivity, glucose control
\item \textbf{Cardiac Rehabilitation}: Consider referral if not previously completed
\item \textbf{Progression}: Track with pedometer/activity tracker, goal 7000-10,000 steps daily
\end{itemize}
\textbf{Self-Monitoring}:
\begin{itemize}[leftmargin=*]
\item \textbf{Daily}:
\begin{itemize}
\item Weight (same time, same scale) - report gain $>$2-3 lbs in 2 days
\item Blood glucose: Fasting and pre-dinner
\item Blood pressure: Morning and evening
\end{itemize}
\item \textbf{Weekly}:
\begin{itemize}
\item Symptom check (dyspnea, edema, chest pain, hypoglycemia frequency)
\item Medication adherence review
\end{itemize}
\item \textbf{Recording}: Use logbook or smartphone app (MyChart, Apple Health)
\end{itemize}
\textbf{Other Lifestyle Factors}:
\begin{itemize}[leftmargin=*]
\item \textbf{CPAP Adherence}: Continue nightly use, download compliance data quarterly
\item \textbf{Smoking}: [If applicable - cessation interventions]
\item \textbf{Alcohol}: Limit to $\leq$1 drink/day (heart failure, diabetes management)
\item \textbf{Stress Management}: Mindfulness, adequate sleep, social engagement
\end{itemize}
\subsection*{4.3 Disease-Specific Monitoring and Screening}
\textbf{Diabetes Monitoring}:
\begin{itemize}[leftmargin=*]
\item HbA1c every 3 months until at goal, then every 6 months
\item Lipid panel annually
\item Urine albumin-to-creatinine ratio annually
\item Comprehensive foot exam every visit, monofilament testing annually
\item Dilated eye exam annually (ophthalmology)
\item Dental exam every 6 months (periodontal disease link)
\end{itemize}
\textbf{Heart Failure Monitoring}:
\begin{itemize}[leftmargin=*]
\item Daily weights, report significant changes
\item BNP or NT-proBNP when symptoms change
\item Echocardiogram annually or if clinical change
\item EKG annually
\item Functional assessment (6-minute walk test) periodically
\end{itemize}
\textbf{CKD Monitoring}:
\begin{itemize}[leftmargin=*]
\item eGFR and creatinine every 3-6 months
\item Urine ACR annually
\item CBC (anemia), CMP (electrolytes, calcium, phosphorus) every 6 months
\item Vitamin D, PTH if indicated
\item Bone density scan (increased fracture risk)
\end{itemize}
\textbf{Preventive Care}:
\begin{itemize}[leftmargin=*]
\item Influenza vaccine annually
\item Pneumococcal vaccines (PCV20 or PCV15+PPSV23) per ACIP guidelines
\item COVID-19 vaccination per current recommendations
\item Zoster vaccine (Shingrix)
\item Colorectal cancer screening per age guidelines
\item [Other age/sex-appropriate screenings]
\end{itemize}
% ===== SECTION 5: CARE COORDINATION =====
\section*{5. Care Coordination and Communication}
\subsection*{Provider Communication Plan}
\begin{tabularx}{\textwidth}{|l|X|X|}
\hline
\textbf{Provider} & \textbf{Visit Frequency} & \textbf{Communication/Coordination} \\ \hline
Primary Care & Every 3 months & Care plan coordinator, medication reconciliation, preventive care \\ \hline
Cardiology & Every 4-6 months & HF medication optimization, EF monitoring, device consideration \\ \hline
Endocrinology & Every 3-4 months & Diabetes management, insulin titration, complications screening \\ \hline
Nephrology & As needed (if eGFR $<$30 or rapid decline) & CKD management, dialysis planning if needed \\ \hline
Dietitian & Monthly x3, then quarterly & Nutrition counseling, meal planning \\ \hline
Pharmacist & Quarterly & Medication review, adherence counseling, cost optimization \\ \hline
Care Coordinator & Monthly phone check-in & Appointment scheduling, barrier identification, education \\ \hline
\end{tabularx}
\subsection*{Information Sharing}
\begin{itemize}[leftmargin=*]
\item Shared EHR access for all providers in health system
\item Medication reconciliation after each specialist visit
\item Lab results shared via patient portal and provider notifications
\item Care plan accessible to all team members
\item Patient carries medication list and problem list
\end{itemize}
\subsection*{Care Transitions Management}
\textbf{Hospital Discharge Protocol}:
\begin{itemize}[leftmargin=*]
\item PCP notified within 24 hours of admission and discharge
\item Follow-up appointment within 7 days of discharge
\item Medication reconciliation at discharge and first follow-up
\item Red flags review: HF exacerbation signs, hyperglycemia, AKI
\end{itemize}
\textbf{Specialty Referral Coordination}:
\begin{itemize}[leftmargin=*]
\item Care coordinator ensures specialist appointments scheduled
\item Specialist notes reviewed by PCP within 1 week
\item Treatment recommendations integrated into care plan
\item Conflicting recommendations discussed among providers
\end{itemize}
% ===== SECTION 6: MONITORING AND OUTCOMES =====
\section*{6. Monitoring Parameters and Quality Measures}
\subsection*{Clinical Outcomes Dashboard}
\begin{longtable}{|p{3.5cm}|p{2.5cm}|p{2cm}|p{2cm}|p{3cm}|}
\hline
\textbf{Parameter} & \textbf{Baseline} & \textbf{Target} & \textbf{Current} & \textbf{Frequency} \\ \hline
\endfirsthead
\hline
\textbf{Parameter} & \textbf{Baseline} & \textbf{Target} & \textbf{Current} & \textbf{Frequency} \\ \hline
\endhead
HbA1c & 8.2\% & $<$7\% & [update] & Q3-6 months \\ \hline
Fasting Glucose & 165 mg/dL & 100-130 & [update] & Daily (patient), labs Q3mo \\ \hline
Blood Pressure & 142/86 & $<$130/80 & [update] & Daily (patient), each visit \\ \hline
LDL Cholesterol & 65 mg/dL & $<$70 & At goal & Annually \\ \hline
eGFR & 38 mL/min & Stable ($\pm$5) & [update] & Every 3-6 months \\ \hline
Urine ACR & 180 mg/g & $<$100 & [update] & Annually \\ \hline
Weight & [baseline] lbs & -10 lbs (5\%) & [update] & Daily (patient), each visit \\ \hline
BNP/NT-proBNP & [if available] & Stable & [update] & When symptomatic \\ \hline
Ejection Fraction & 35\% & Monitor & [date of last echo] & Annually or if change \\ \hline
\end{longtable}
\subsection*{Quality Measure Tracking (HEDIS/CMS)}
\begin{itemize}[leftmargin=*]
\item ✓ Diabetes HbA1c testing (every 6 months)
\item ☐ Diabetes HbA1c control ($<$8\%) - \textit{Target: achieve}
\item ✓ Diabetes eye exam (annual dilated)
\item ☐ Diabetes medical attention for nephropathy (urine ACR) - \textit{Due [month]}
\item ✓ Blood pressure control ($<$140/90 for diabetes)
\item ✓ Statin therapy for ASCVD
\item ✓ ACE/ARB therapy for diabetes with hypertension
\item ✓ Beta-blocker for HFrEF
\item ☐ Flu vaccine current year - \textit{Due [month]}
\item ✓ Pneumococcal vaccine
\end{itemize}
% ===== SECTION 7: PATIENT EDUCATION AND ACTIVATION =====
\section*{7. Patient Education and Self-Management Support}
\subsection*{Disease Education Completed}
\begin{itemize}[leftmargin=*]
\item \textbf{Diabetes}: Pathophysiology, complications, importance of glucose control, hypoglycemia recognition
\item \textbf{Heart Failure}: How heart failure affects body, medication importance, fluid/sodium restrictions, warning signs
\item \textbf{CKD}: Kidney function, progression risk, renal protection strategies, medication precautions
\item \textbf{Medication Purposes}: Why each medication is prescribed, expected benefits
\item \textbf{Lifestyle Impact}: How diet, exercise, weight loss benefit all conditions
\end{itemize}
\subsection*{Self-Management Skills Training}
\begin{itemize}[leftmargin=*]
\item ✓ Blood glucose monitoring technique
\item ✓ Insulin injection technique and storage
\item ✓ Home blood pressure monitoring
\item ✓ Daily weight tracking and interpretation
\item ✓ Symptom recognition (HF exacerbation, hypoglycemia, hyperglycemia)
\item ✓ Medication organization (pill box use)
\item ☐ Dietary skills: Carb counting, label reading, low-sodium food selection
\item ☐ Sick day management (when to call, medication adjustments)
\end{itemize}
\subsection*{Warning Signs - When to Call Provider}
\textbf{Call office same day or go to ED if}:
\begin{itemize}[leftmargin=*]
\item Weight gain $>$2-3 lbs in 2 days or 5 lbs in 1 week (heart failure)
\item Increased shortness of breath, cannot lie flat, new leg swelling
\item Chest pain or pressure
\item Blood glucose consistently $>$300 or $<$60 mg/dL
\item Decreased urine output, dark urine, swelling
\item Dizziness, lightheadedness, syncope
\end{itemize}
\subsection*{Resources and Support}
\begin{itemize}[leftmargin=*]
\item Diabetes self-management education program (DSMES)
\item Cardiac rehabilitation program
\item Patient portal for lab results, messaging, educational materials
\item American Diabetes Association (diabetes.org) resources
\item American Heart Association (heart.org) HF information
\item National Kidney Foundation (kidney.org) CKD education
\item Local support groups [if available]
\end{itemize}
% ===== SECTION 8: CONTINGENCY PLANNING =====
\section*{8. Contingency Planning and Risk Mitigation}
\subsection*{Hospital Readmission Prevention}
\textbf{High-Risk Period}: 30 days post-discharge
\textbf{Prevention Strategies}:
\begin{itemize}[leftmargin=*]
\item Early follow-up appointment (within 7 days)
\item Medication reconciliation and adherence check
\item Symptom monitoring escalation
\item Care coordinator phone call within 48 hours of discharge
\item Access to nurse advice line 24/7
\end{itemize}
\subsection*{Disease Progression Planning}
\textbf{If CKD progresses to Stage 4-5}:
\begin{itemize}[leftmargin=*]
\item Nephrology referral for CKD education and dialysis planning
\item Vascular access planning if eGFR $<$20
\item Medication adjustments for reduced renal clearance
\item Anemia management optimization (ESA if needed)
\item Advance care planning discussions
\end{itemize}
\textbf{If HF worsens to NYHA Class III-IV}:
\begin{itemize}[leftmargin=*]
\item Consider ICD/CRT device evaluation
\item Advanced therapies discussion (LVAD, transplant evaluation if appropriate)
\item Palliative care consultation for symptom management
\item Home health nursing for weight/symptom monitoring
\end{itemize}
\subsection*{Advance Care Planning}
\begin{itemize}[leftmargin=*]
\item Goals of care discussion: [Patient preferences documented]
\item Healthcare proxy: [Name, relationship] designated
\item Advance directive: ☐ Completed / ☐ To complete
\item CPR preferences: [Discussed, documented in chart]
\item Dialysis preferences: Patient expresses desire to avoid if possible
\end{itemize}
% ===== SECTION 9: FOLLOW-UP SCHEDULE =====
\section*{9. Follow-Up and Reassessment Schedule}
\subsection*{Appointment Calendar}
\begin{longtable}{|l|l|p{7cm}|}
\hline
\textbf{Timeframe} & \textbf{Provider} & \textbf{Purpose} \\ \hline
\endfirsthead
\hline
\textbf{Timeframe} & \textbf{Provider} & \textbf{Purpose} \\ \hline
\endhead
Week 2 & Care Coordinator (phone) & Check medication tolerability, answer questions, reinforce education \\ \hline
Month 1 & PCP & Add empagliflozin, assess insulin titration, review home monitoring logs \\ \hline
Month 2 & Dietitian & Nutrition counseling, meal planning, sodium/carb education \\ \hline
Month 3 & PCP & HbA1c check, labs (CMP, lipids), medication review, preventive care update \\ \hline
Month 3-4 & Cardiology & HF assessment, beta-blocker titration, consider ARNI \\ \hline
Month 3-4 & Endocrinology & Diabetes management review, complications screening \\ \hline
Month 6 & PCP & Comprehensive reassessment, all labs, update care plan, goal review \\ \hline
Ongoing & Quarterly PCP & Chronic disease management visits \\ \hline
\end{longtable}
\subsection*{Plan Reassessment}
This care plan will be formally reassessed and updated:
\begin{itemize}[leftmargin=*]
\item Every 6 months (routine)
\item After hospitalization or ED visit
\item With significant change in clinical status
\item When new diagnoses are added
\item When treatment goals are achieved or modified
\item At patient or provider request
\end{itemize}
% ===== SECTION 10: SIGNATURES =====
\vspace{2em}
\section*{10. Provider Signature and Attestation}
This comprehensive chronic disease management plan has been reviewed with the patient. The patient demonstrates understanding of all chronic conditions, treatment goals, medications, lifestyle recommendations, self-monitoring requirements, warning signs, and when to seek care. Patient's values and preferences have been incorporated through shared decision-making.
\vspace{1em}
\begin{tabular}{ll}
Provider Signature: & \rule{7cm}{0.5pt} \\[1em]
Provider Name/Credentials: & \rule{7cm}{0.5pt} \\[1em]
Date: & \rule{4cm}{0.5pt} \\[2em]
\end{tabular}
\subsection*{Care Team Acknowledgment (Optional)}
Care team members have reviewed this integrated care plan and will coordinate care accordingly.
\vspace{0.5em}
\textit{[Additional signature lines for cardiologist, endocrinologist, care coordinator as appropriate]}
\vspace{2em}
\begin{center}
\rule{\textwidth}{1pt}\\
\textbf{End of Chronic Disease Management Plan}\\
This document contains confidential patient information protected by HIPAA.
\end{center}
\end{document}
% ========== NOTES FOR USERS ==========
%
% KEY FEATURES:
% - Integrates multiple chronic conditions into unified plan
% - Addresses medication interactions and contraindications across conditions
% - Coordinates care across multiple specialistsUtilizes shared goals when conditions overlap (e.g., SGLT2i for DM + HF + CKD)
% - Emphasizes patient self-management and activation
% - Tracks quality measures and outcomes
%
% CUSTOMIZATION:
% - Adjust problem list based on patient's specific conditions
% - Modify goals for disease severity and patient capabilities
% - Adapt medication regimen to formulary and patient tolerance
% - Coordinate specialist involvement based on availability and need
%
% COMPILATION:
% pdflatex chronic_disease_management_plan.tex
% General Medical Treatment Plan Template
% For primary care and chronic disease management
% Last updated: 2025
\documentclass[11pt,letterpaper]{article}
% Packages
\usepackage[top=1in,bottom=1in,left=1in,right=1in]{geometry}
\usepackage{amsmath,amssymb}
\usepackage[utf8]{inputenc}
\usepackage{graphicx}
\usepackage{array}
\usepackage{longtable}
\usepackage{booktabs}
\usepackage{enumitem}
\usepackage{xcolor}
\usepackage{fancyhdr}
\usepackage{lastpage}
\usepackage{tabularx}
\usepackage[most]{tcolorbox}
% Header and footer
\pagestyle{fancy}
\fancyhf{}
\lhead{General Medical Treatment Plan}
\rhead{Page \thepage\ of \pageref{LastPage}}
\lfoot{Date Created: \today}
\rfoot{Confidential Patient Information}
% Title formatting
\usepackage{titlesec}
\titleformat{\section}{\large\bfseries}{\thesection}{1em}{}
\titleformat{\subsection}{\normalsize\bfseries}{\thesubsection}{1em}{}
\begin{document}
% Title
\begin{center}
{\Large\bfseries MEDICAL TREATMENT PLAN}\\[0.5em]
{\large General Medicine \& Chronic Disease Management}\\[0.5em]
\rule{\textwidth}{1pt}
\end{center}
\vspace{1em}
% ===== TREATMENT PLAN HIGHLIGHTS (Foundation Medicine Model) =====
\begin{tcolorbox}[colback=blue!5!white,colframe=blue!75!black,title=\textbf{TREATMENT PLAN HIGHLIGHTS},fonttitle=\bfseries\large]
\textbf{Key Diagnosis:} [Primary diagnosis with ICD-10 code, severity/stage]
\vspace{0.3em}
\textbf{Primary Treatment Goals:}
\begin{itemize}[leftmargin=*,itemsep=0pt]
\item [Goal 1 - e.g., Reduce HbA1c from 8.5\% to $<$7\% within 3 months]
\item [Goal 2 - e.g., Achieve blood pressure $<$130/80 mmHg within 8 weeks]
\item [Goal 3 - e.g., Weight loss of 7-10\% body weight over 6 months]
\end{itemize}
\vspace{0.3em}
\textbf{Main Interventions:}
\begin{itemize}[leftmargin=*,itemsep=0pt]
\item \textit{Pharmacological:} [Key medications - e.g., Metformin 1000mg BID, Lisinopril 10mg daily]
\item \textit{Non-pharmacological:} [Lifestyle modifications - e.g., Mediterranean diet, 150 min/week exercise]
\item \textit{Monitoring:} [Key parameters - e.g., HbA1c every 3 months, home BP daily]
\end{itemize}
\vspace{0.3em}
\textbf{Timeline:} [Duration - e.g., Intensive initiation (4 weeks), Adjustment phase (8 weeks), Maintenance (ongoing)]
\end{tcolorbox}
\vspace{1em}
% ===== SECTION 1: PATIENT INFORMATION =====
\section*{1. Patient Information}
\textbf{HIPAA Notice}: All identifiable information must be removed or de-identified per Safe Harbor method before sharing this document. Remove: name, dates (except year), addresses, phone/fax, email, SSN, medical record numbers, account numbers, photos, and other unique identifiers.
\vspace{0.5em}
\begin{tabularx}{\textwidth}{|l|X|}
\hline
\textbf{Patient ID} & [De-identified code, e.g., PT-001] \\ \hline
\textbf{Age Range} & [e.g., 55-60 years] \\ \hline
\textbf{Sex} & [Male/Female/Other] \\ \hline
\textbf{Race/Ethnicity} & [If relevant to treatment] \\ \hline
\textbf{Date of Plan} & [Month/Year only] \\ \hline
\textbf{Provider} & [Name, MD/DO/NP/PA, Credentials] \\ \hline
\textbf{Facility} & [Healthcare facility name] \\ \hline
\end{tabularx}
\vspace{1em}
\subsection*{Active Medical Conditions}
\begin{itemize}[leftmargin=*]
\item \textbf{Primary Diagnosis}: [Condition with ICD-10 code]
\item \textbf{Secondary Diagnoses}:
\begin{itemize}
\item [Comorbidity 1 with ICD-10 code]
\item [Comorbidity 2 with ICD-10 code]
\item [Additional conditions as needed]
\end{itemize}
\end{itemize}
\subsection*{Current Medications}
\begin{longtable}{|p{3.5cm}|p{2cm}|p{2cm}|p{5cm}|}
\hline
\textbf{Medication} & \textbf{Dose} & \textbf{Frequency} & \textbf{Indication} \\ \hline
\endfirsthead
\hline
\textbf{Medication} & \textbf{Dose} & \textbf{Frequency} & \textbf{Indication} \\ \hline
\endhead
Medication 1 & [e.g., 10mg] & [e.g., daily] & [Indication] \\ \hline
Medication 2 & [e.g., 50mg] & [e.g., BID] & [Indication] \\ \hline
[Add rows as needed] & & & \\ \hline
\end{longtable}
\subsection*{Allergies}
\begin{itemize}[leftmargin=*]
\item \textbf{Drug Allergies}: [List medications and reactions, or NKDA]
\item \textbf{Food/Environmental}: [If relevant to treatment]
\end{itemize}
\subsection*{Baseline Assessment}
\begin{itemize}[leftmargin=*]
\item \textbf{Functional Status}: [Independent/requires assistance/dependent for ADLs]
\item \textbf{Cognitive Status}: [Alert and oriented/impairment if present]
\item \textbf{Social Support}: [Lives alone/with family, support system]
\item \textbf{Key Baseline Values}: [e.g., HbA1c 8.5\%, BP 145/90, BMI 32, eGFR 55]
\end{itemize}
% ===== SECTION 2: DIAGNOSIS AND ASSESSMENT =====
\section*{2. Diagnosis and Assessment Summary}
\subsection*{Primary Diagnosis}
\textbf{Diagnosis}: [Full diagnosis name]\\
\textbf{ICD-10 Code}: [e.g., E11.9 for Type 2 Diabetes Mellitus without complications]\\
\textbf{Severity}: [Mild/Moderate/Severe or stage classification]\\
\textbf{Duration}: [Time since diagnosis]
\subsection*{Clinical Presentation}
[Describe current symptoms, functional limitations, and impact on quality of life. Include relevant exam findings and diagnostic test results.]
\subsection*{Risk Stratification}
\begin{itemize}[leftmargin=*]
\item \textbf{Cardiovascular Risk}: [e.g., ASCVD 10-year risk 15\%]
\item \textbf{Complications Risk}: [e.g., high risk for diabetic nephropathy]
\item \textbf{Other Risk Factors}: [e.g., fall risk, frailty, polypharmacy]
\end{itemize}
\subsection*{Prognostic Considerations}
[Discuss expected disease course, factors affecting prognosis, and rationale for treatment intensity.]
% ===== SECTION 3: TREATMENT GOALS =====
\section*{3. Treatment Goals (SMART Format)}
\textbf{SMART Criteria}: All goals should be \textbf{S}pecific, \textbf{M}easurable, \textbf{A}chievable, \textbf{R}elevant, and \textbf{T}ime-bound.
\subsection*{Short-Term Goals (1-3 months)}
\begin{enumerate}[leftmargin=*]
\item \textbf{Goal 1}: [e.g., Reduce HbA1c from 8.5\% to $<$7.5\%]
\begin{itemize}
\item \textit{Specific}: Reduce HbA1c by at least 1 percentage point
\item \textit{Measurable}: HbA1c lab value
\item \textit{Achievable}: With medication initiation and lifestyle changes
\item \textit{Relevant}: Reduce microvascular complication risk
\item \textit{Time-bound}: Achieve within 3 months (next follow-up)
\end{itemize}
\item \textbf{Goal 2}: [e.g., Decrease systolic blood pressure to $<$130 mmHg]
\begin{itemize}
\item \textit{Specific}: Achieve BP $<$130/80 mmHg
\item \textit{Measurable}: Office and home BP measurements
\item \textit{Achievable}: With medication optimization
\item \textit{Relevant}: Reduce cardiovascular event risk
\item \textit{Time-bound}: Within 8 weeks
\end{itemize}
\item \textbf{Goal 3}: [Additional short-term goal]
\end{enumerate}
\subsection*{Long-Term Goals (6-12 months)}
\begin{enumerate}[leftmargin=*]
\item \textbf{Goal 1}: [e.g., Maintain HbA1c $<$7\% and prevent diabetic complications]
\begin{itemize}
\item \textit{Success criteria}: HbA1c $<$7\%, no new retinopathy/nephropathy/neuropathy
\item \textit{Timeline}: Ongoing, assessed every 3-6 months
\end{itemize}
\item \textbf{Goal 2}: [e.g., Weight loss of 15 pounds (7\% body weight)]
\begin{itemize}
\item \textit{Success criteria}: BMI reduction from 32 to $<$30
\item \textit{Timeline}: 6-12 months at 1-2 lbs/week
\end{itemize}
\item \textbf{Goal 3}: [e.g., Achieve LDL cholesterol $<$70 mg/dL]
\item \textbf{Goal 4}: [Additional long-term goal as needed]
\end{enumerate}
\subsection*{Patient-Centered Goals}
\begin{itemize}[leftmargin=*]
\item \textbf{Patient Priority 1}: [e.g., "Feel more energetic throughout the day"]
\item \textbf{Patient Priority 2}: [e.g., "Avoid insulin injections if possible"]
\item \textbf{Patient Priority 3}: [e.g., "Continue working full-time"]
\end{itemize}
% ===== SECTION 4: INTERVENTIONS =====
\section*{4. Interventions}
\subsection*{4.1 Pharmacological Interventions}
\begin{longtable}{|p{3cm}|p{2cm}|p{2cm}|p{6.5cm}|}
\hline
\textbf{Medication} & \textbf{Dose} & \textbf{Frequency} & \textbf{Instructions \& Rationale} \\ \hline
\endfirsthead
\hline
\textbf{Medication} & \textbf{Dose} & \textbf{Frequency} & \textbf{Instructions \& Rationale} \\ \hline
\endhead
[e.g., Metformin] & 500mg & BID & \textbf{Start:} Take with meals to reduce GI upset. \textbf{Titration:} Increase to 1000mg BID after 2 weeks if tolerated. \textbf{Target:} 2000mg daily. \textbf{Rationale:} First-line for T2DM, reduces hepatic glucose production. \\ \hline
[e.g., Lisinopril] & 10mg & Daily & \textbf{Instructions:} Take in morning. Monitor BP at home. \textbf{Titration:} May increase to 20mg if BP not at goal in 4 weeks. \textbf{Rationale:} ACE inhibitor for HTN and renal protection in diabetes. \\ \hline
[Additional medications] & & & \\ \hline
\end{longtable}
\textbf{Medication Safety Considerations}:
\begin{itemize}[leftmargin=*]
\item \textbf{Drug Interactions}: [List relevant interactions to monitor]
\item \textbf{Adverse Effects to Monitor}: [e.g., metformin - GI upset, lactic acidosis; lisinopril - cough, hyperkalemia, angioedema]
\item \textbf{Contraindications}: [e.g., metformin if eGFR $<$30]
\item \textbf{Pregnancy Category}: [If relevant to patient]
\end{itemize}
\subsection*{4.2 Non-Pharmacological Interventions}
\textbf{Lifestyle Modifications}:
\begin{itemize}[leftmargin=*]
\item \textbf{Diet}:
\begin{itemize}
\item Mediterranean or DASH diet pattern
\item Carbohydrate counting: 45-60g per meal
\item Reduce saturated fat $<$7\% of calories
\item Sodium restriction $<$2300mg daily
\item Referral to registered dietitian
\end{itemize}
\item \textbf{Exercise}:
\begin{itemize}
\item Aerobic exercise: 150 minutes/week moderate intensity (e.g., brisk walking 30 min 5x/week)
\item Resistance training: 2-3 sessions/week
\item Reduce sedentary time, stand/move every 30 minutes
\end{itemize}
\item \textbf{Smoking Cessation}: [If applicable]
\begin{itemize}
\item Nicotine replacement therapy (patch, gum, lozenge)
\item Consider varenicline or bupropion
\item Behavioral counseling: 1-800-QUIT-NOW
\item Target quit date: [specific date within 1 month]
\end{itemize}
\item \textbf{Weight Management}:
\begin{itemize}
\item Target: 7-10\% body weight loss over 6 months
\item Caloric deficit: 500-750 kcal/day
\item Weekly self-weighing and food diary
\item Consider weight loss program or app
\end{itemize}
\item \textbf{Sleep Hygiene}:
\begin{itemize}
\item Target 7-9 hours nightly
\item Consistent sleep schedule
\item Screen for sleep apnea if indicated
\end{itemize}
\item \textbf{Stress Management}:
\begin{itemize}
\item Mindfulness or meditation practice
\item Stress reduction techniques
\item Adequate social support
\end{itemize}
\end{itemize}
\textbf{Self-Management and Monitoring}:
\begin{itemize}[leftmargin=*]
\item \textbf{Blood Glucose Monitoring}: [Frequency, e.g., fasting and 2hr post-prandial 3x/week]
\item \textbf{Home Blood Pressure}: [Frequency, e.g., daily in AM, record in log]
\item \textbf{Weight Tracking}: [e.g., weekly on same day/time]
\item \textbf{Symptom Diary}: [Track relevant symptoms]
\item \textbf{Medication Adherence}: [Pill box, reminder app]
\end{itemize}
\subsection*{4.3 Procedural and Referral Interventions}
\begin{itemize}[leftmargin=*]
\item \textbf{Specialist Referrals}:
\begin{itemize}
\item [e.g., Endocrinology consultation for diabetes management]
\item [e.g., Ophthalmology for annual dilated eye exam]
\item [e.g., Podiatry for diabetic foot exam]
\item [e.g., Nephrology if eGFR $<$30 or proteinuria]
\end{itemize}
\item \textbf{Diagnostic Testing Schedule}:
\begin{itemize}
\item [e.g., HbA1c every 3 months until at goal, then every 6 months]
\item [e.g., Lipid panel annually]
\item [e.g., Urine albumin-to-creatinine ratio annually]
\item [e.g., Comprehensive metabolic panel every 6 months]
\end{itemize}
\item \textbf{Preventive Care}:
\begin{itemize}
\item Influenza vaccine annually
\item Pneumococcal vaccines (PCV20 or PCV15+PPSV23)
\item COVID-19 vaccination per current guidelines
\item Age-appropriate cancer screenings
\item [Other preventive measures as indicated]
\end{itemize}
\end{itemize}
% ===== SECTION 5: TIMELINE AND SCHEDULE =====
\section*{5. Timeline and Schedule}
\subsection*{Treatment Phases}
\begin{tabularx}{\textwidth}{|l|X|X|}
\hline
\textbf{Phase} & \textbf{Timeframe} & \textbf{Focus} \\ \hline
Intensive Initiation & Weeks 1-4 & Medication titration, lifestyle education, baseline monitoring \\ \hline
Adjustment & Weeks 5-12 & Optimize medications, reinforce lifestyle changes, assess goal progress \\ \hline
Maintenance & Months 4-12 & Sustain improvements, prevent complications, long-term adherence \\ \hline
Ongoing & $>$12 months & Chronic disease management, annual assessments, update goals \\ \hline
\end{tabularx}
\subsection*{Appointment Schedule}
\begin{tabularx}{\textwidth}{|l|X|X|}
\hline
\textbf{Timepoint} & \textbf{Visit Type} & \textbf{Key Activities} \\ \hline
Week 2 & Phone/telehealth & Check medication tolerance, answer questions \\ \hline
Week 4 & Office visit & Medication adjustment, BP check, labs, review monitoring \\ \hline
Week 8 & Office visit & Assess progress toward goals, reinforce lifestyle \\ \hline
Month 3 & Office visit & HbA1c, comprehensive assessment, goal evaluation \\ \hline
Month 6 & Office visit & Reassess all goals, update plan, labs \\ \hline
Month 12 & Annual exam & Comprehensive evaluation, preventive care, specialty referrals \\ \hline
Ongoing & Every 3-6 months & Per chronic disease management protocol \\ \hline
\end{tabularx}
\subsection*{Milestone Assessments}
\begin{itemize}[leftmargin=*]
\item \textbf{Month 1}: Medication tolerance, lifestyle initiation, home monitoring established
\item \textbf{Month 3}: HbA1c $<$7.5\%, BP $<$130/80, 3-5 lb weight loss
\item \textbf{Month 6}: HbA1c $<$7\%, sustained BP control, 8-10 lb weight loss
\item \textbf{Month 12}: All long-term goals achieved or revised, complication screening complete
\end{itemize}
% ===== SECTION 6: MONITORING PARAMETERS =====
\section*{6. Monitoring Parameters}
\subsection*{Clinical Outcomes to Track}
\begin{longtable}{|p{4cm}|p{3cm}|p{3cm}|p{4cm}|}
\hline
\textbf{Parameter} & \textbf{Baseline} & \textbf{Target} & \textbf{Frequency} \\ \hline
\endfirsthead
\hline
\textbf{Parameter} & \textbf{Baseline} & \textbf{Target} & \textbf{Frequency} \\ \hline
\endhead
HbA1c & [e.g., 8.5\%] & $<$7\% & Every 3 months until stable, then every 6 months \\ \hline
Fasting Glucose & [e.g., 165 mg/dL] & 80-130 mg/dL & Home monitoring per schedule \\ \hline
Blood Pressure & [e.g., 145/90] & $<$130/80 mmHg & Daily home, every office visit \\ \hline
Weight/BMI & [e.g., 210 lb, BMI 32] & 195 lb, BMI $<$30 & Weekly at home, every visit \\ \hline
LDL Cholesterol & [e.g., 135 mg/dL] & $<$70 mg/dL & Every 6-12 months \\ \hline
eGFR & [e.g., 55 mL/min] & Stable, $>$45 & Every 6 months \\ \hline
Urine ACR & [e.g., normal] & $<$30 mg/g & Annually \\ \hline
[Add additional parameters] & & & \\ \hline
\end{longtable}
\subsection*{Assessment Tools and Scales}
\begin{itemize}[leftmargin=*]
\item \textbf{Diabetes Distress Scale}: [Assess emotional burden of diabetes management]
\item \textbf{SF-12 or PROMIS}: [Quality of life assessment]
\item \textbf{Medication Adherence}: [Morisky scale or refill tracking]
\item \textbf{[Other relevant scales]}: [e.g., PHQ-2 for depression screening]
\end{itemize}
\subsection*{Safety Monitoring}
\begin{itemize}[leftmargin=*]
\item \textbf{Hypoglycemia}: Frequency of blood glucose $<$70 mg/dL, symptoms
\item \textbf{Medication Adverse Effects}: GI upset, cough, dizziness, other symptoms
\item \textbf{Hyperkalemia}: Potassium level if on ACE inhibitor/ARB
\item \textbf{Renal Function}: Monitor eGFR for metformin safety, ACE/ARB effects
\end{itemize}
\subsection*{Thresholds for Intervention}
\begin{itemize}[leftmargin=*]
\item \textbf{Urgent}: Blood glucose $>$300 or $<$50, BP $>$180/110, chest pain, severe symptoms
\item \textbf{Escalate Treatment}: No improvement in HbA1c after 3 months, BP above goal after 8 weeks
\item \textbf{Modify Plan}: Intolerable side effects, patient preference change, new comorbidities
\end{itemize}
% ===== SECTION 7: EXPECTED OUTCOMES =====
\section*{7. Expected Outcomes and Prognosis}
\textbf{Anticipated Treatment Response}: With adherence, expect HbA1c reduction of 1-1.5\%, BP reduction of 10-15 mmHg, and 5-10\% weight loss over 6 months. Improvements visible at 4-8 weeks (BP, glucose), with HbA1c changes by 3 months.
\vspace{0.5em}
\textbf{Long-Term Benefits}: Reduced complication risk (cardiovascular events, retinopathy, nephropathy), improved quality of life, maintained independence and functional status.
% ===== SECTION 8: FOLLOW-UP PLAN =====
\section*{8. Follow-Up Plan}
\subsection*{Scheduled Appointments}
\begin{itemize}[leftmargin=*]
\item \textbf{Next Visit}: [Date/timeframe - e.g., 4 weeks from today]
\item \textbf{Visit Purpose}: [Medication adjustment, lab review, goal assessment]
\item \textbf{Ongoing Schedule}: See Appointment Schedule in Section 5
\end{itemize}
\subsection*{Communication Plan}
\begin{itemize}[leftmargin=*]
\item \textbf{Between-Visit Contact}: Phone call at 2 weeks to assess medication tolerance
\item \textbf{Lab Results}: Will call with results within 3-5 business days
\item \textbf{Questions}: Call office at [phone], patient portal messaging
\item \textbf{Prescription Refills}: Via patient portal or pharmacy automated refill
\end{itemize}
\subsection*{Emergency Procedures}
\textbf{Call 911 immediately for}:
\begin{itemize}[leftmargin=*]
\item Chest pain, shortness of breath, or stroke symptoms
\item Severe hypoglycemia with confusion or loss of consciousness
\item Severe allergic reaction (angioedema, anaphylaxis)
\end{itemize}
\textbf{Call office same day for}:
\begin{itemize}[leftmargin=*]
\item Blood glucose consistently $>$300 or $<$60 mg/dL
\item Blood pressure $>$180/110 mmHg
\item Persistent severe medication side effects
\item Fever, infection, or acute illness (may need medication adjustment)
\end{itemize}
\subsection*{Transition Planning}
\begin{itemize}[leftmargin=*]
\item \textbf{If Hospitalized}: Provide this treatment plan to hospital team, resume medications on discharge
\item \textbf{Specialist Co-Management}: Share plan with all specialists, coordinate medication changes
\item \textbf{Future Considerations}: [e.g., may need insulin if oral medications insufficient]
\end{itemize}
% ===== SECTION 9: PATIENT EDUCATION =====
\section*{9. Patient Education and Self-Management}
\textbf{Key Education Topics}: Disease understanding, complication risks, treatment rationale, self-monitoring techniques (glucose, BP), medication administration, diet/nutrition basics, exercise safety, sick day management.
\vspace{0.5em}
\textbf{Critical Warning Signs}:
\begin{itemize}[leftmargin=*,itemsep=0pt]
\item \textit{Emergency (call 911)}: Chest pain, severe hypoglycemia with confusion, stroke symptoms
\item \textit{Call office same day}: Glucose $>$300 or $<$60 mg/dL, BP $>$180/110, severe medication side effects
\item \textit{Urgent evaluation}: Diabetic foot wounds, severe hyperglycemia with symptoms
\end{itemize}
\vspace{0.5em}
\textbf{Support Resources}: DSMES referral, registered dietitian, educational materials, support groups, tracking technology, financial assistance programs as needed.
% ===== SECTION 10: RISK MITIGATION AND SAFETY =====
\section*{10. Risk Mitigation and Safety}
\textbf{Key Medication Safety Concerns}:
\begin{itemize}[leftmargin=*,itemsep=0pt]
\item \textit{Metformin}: Monitor eGFR every 6 months; hold if eGFR $<$30, during acute illness, or 48 hours before contrast
\item \textit{ACE inhibitor}: Check K+ and creatinine at 1-2 weeks, then every 6 months; hold during dehydration/AKI
\item \textit{Hypoglycemia}: Low risk without insulin/sulfonylureas; educate on recognition and 15-15 rule
\end{itemize}
\vspace{0.5em}
\textbf{Complication Prevention}: Annual eye exam, foot exam, and urine ACR; aspirin if ASCVD risk $>$10\%; BP and glucose control reduces cardiovascular, retinopathy, nephropathy, and neuropathy risks.
\vspace{0.5em}
\textbf{Emergency Actions}: Severe hypoglycemia ($<$50, confusion) - glucagon then 911; chest pain/stroke - call 911; hyperglycemia $>$300 with symptoms - hydrate and call office; severe medication side effects - stop medication, call same day.
% ===== SECTION 11: PROVIDER SIGNATURE =====
\vspace{2em}
\section*{11. Provider Signature and Attestation}
I have reviewed this treatment plan with the patient. The patient demonstrates understanding of the diagnosis, treatment rationale, goals, interventions, self-management requirements, warning signs, and when to seek emergency care. The patient agrees to this treatment plan and has had the opportunity to ask questions. Shared decision-making was employed, and patient preferences were incorporated.
\vspace{1em}
\begin{tabular}{ll}
Provider Signature: & \rule{7cm}{0.5pt} \\[1em]
Provider Name/Credentials: & \rule{7cm}{0.5pt} \\[1em]
Date: & \rule{4cm}{0.5pt} \\[2em]
\end{tabular}
\subsection*{Patient Acknowledgment (Optional)}
I have reviewed this treatment plan with my healthcare provider. I understand my diagnosis, treatment goals, medications, lifestyle recommendations, self-monitoring requirements, and when to seek medical attention. I agree to follow this plan and contact my provider with questions or concerns.
\vspace{1em}
\begin{tabular}{ll}
Patient/Representative Signature: & \rule{7cm}{0.5pt} \\[1em]
Date: & \rule{4cm}{0.5pt} \\
\end{tabular}
\vspace{2em}
\begin{center}
\rule{\textwidth}{1pt}\\
\textbf{End of Treatment Plan}\\
This document contains confidential patient information protected by HIPAA.
\end{center}
\end{document}
% ========== NOTES FOR USERS ==========
%
% CUSTOMIZATION INSTRUCTIONS:
% 1. Replace all bracketed placeholders [like this] with patient-specific information
% 2. Remove or add sections as appropriate for the clinical condition
% 3. Ensure all SMART goals meet criteria (Specific, Measurable, Achievable, Relevant, Time-bound)
% 4. Include evidence-based interventions per current clinical guidelines
% 5. De-identify all protected health information before sharing
%
% COMPILATION:
% pdflatex general_medical_treatment_plan.tex
%
% VALIDATION:
% Run check_completeness.py and validate_treatment_plan.py before finalizing
% medical_treatment_plan.sty
% Professional Medical Treatment Plan Style
% Provides modern, clean styling for clinical treatment plans
\NeedsTeXFormat{LaTeX2e}
\ProvidesPackage{medical_treatment_plan}[2025/11/05 Medical Treatment Plan Style]
% Required packages
\RequirePackage[margin=1in, top=1.2in, bottom=1.2in]{geometry}
\RequirePackage{graphicx}
\RequirePackage{xcolor}
\RequirePackage[most]{tcolorbox}
\RequirePackage{tikz}
\RequirePackage{fontspec}
\RequirePackage{fancyhdr}
\RequirePackage{titlesec}
\RequirePackage{enumitem}
\RequirePackage{booktabs}
\RequirePackage{longtable}
\RequirePackage{array}
\RequirePackage{colortbl}
\RequirePackage{hyperref}
\RequirePackage{natbib}
% Color scheme - Professional medical blues and grays
\definecolor{primaryblue}{RGB}{0, 102, 153} % Deep medical blue
\definecolor{secondaryblue}{RGB}{102, 178, 204} % Light blue
\definecolor{accentblue}{RGB}{0, 153, 204} % Bright accent
\definecolor{darkgray}{RGB}{64, 64, 64} % Dark gray for text
\definecolor{lightgray}{RGB}{245, 245, 245} % Light background
\definecolor{medgray}{RGB}{200, 200, 200} % Medium gray
\definecolor{warningred}{RGB}{204, 0, 0} % For warnings
\definecolor{successgreen}{RGB}{0, 153, 76} % For success/goals
% Fonts (if using XeLaTeX/LuaLaTeX) - use default fonts if custom fonts not available
% \IfFileExists{lato}{\setmainfont{Lato}}{}
% \IfFileExists{roboto}{\setsansfont{Roboto}}{}
% Hyperlink setup
\hypersetup{
colorlinks=true,
linkcolor=primaryblue,
citecolor=primaryblue,
urlcolor=accentblue,
pdfborder={0 0 0}
}
% Header and footer styling
\setlength{\headheight}{22pt}
\pagestyle{fancy}
\fancyhf{}
\fancyhead[L]{\color{primaryblue}\sffamily\small\textbf{Diabetes Treatment Plan}}
\fancyhead[R]{\color{darkgray}\sffamily\small Patient Age: 23}
\fancyfoot[C]{\color{darkgray}\small\thepage}
\renewcommand{\headrulewidth}{2pt}
\renewcommand{\headrule}{\hbox to\headwidth{\color{primaryblue}\leaders\hrule height \headrulewidth\hfill}}
\renewcommand{\footrulewidth}{0.5pt}
\renewcommand{\footrule}{\hbox to\headwidth{\color{medgray}\leaders\hrule height \footrulewidth\hfill}}
% Section styling
\titleformat{\section}
{\color{primaryblue}\Large\sffamily\bfseries}
{\thesection}{1em}{}
[\color{primaryblue}\titlerule]
\titleformat{\subsection}
{\color{accentblue}\large\sffamily\bfseries}
{\thesubsection}{1em}{}
\titleformat{\subsubsection}
{\color{darkgray}\normalsize\sffamily\bfseries}
{\thesubsubsection}{1em}{}
% Title page styling
\renewcommand{\maketitle}{
\begin{tcolorbox}[
enhanced,
colback=primaryblue,
colframe=primaryblue,
arc=0mm,
boxrule=0pt,
left=20pt,
right=20pt,
top=30pt,
bottom=30pt,
width=\textwidth
]
\color{white}
\begin{center}
{\Huge\sffamily\bfseries Individualized Diabetes\\Treatment Plan}\\[10pt]
{\Large\sffamily 23-Year-Old Male Patient with Type 2 Diabetes}\\[15pt]
{\large\sffamily Comprehensive Evidence-Based Care Plan}\\[8pt]
{\normalsize\sffamily\color{secondaryblue}\today}
\end{center}
\end{tcolorbox}
\vspace{1cm}
}
% Custom boxes for different content types
% Info box
\newtcolorbox{infobox}[1][]{
enhanced,
colback=lightgray,
colframe=primaryblue,
arc=3mm,
boxrule=1.5pt,
left=10pt,
right=10pt,
top=10pt,
bottom=10pt,
title=#1,
fonttitle=\sffamily\bfseries,
coltitle=white,
colbacktitle=primaryblue
}
% Warning box
\newtcolorbox{warningbox}[1][Warning]{
enhanced,
colback=yellow!10,
colframe=warningred,
arc=3mm,
boxrule=1.5pt,
left=10pt,
right=10pt,
top=10pt,
bottom=10pt,
title=#1,
fonttitle=\sffamily\bfseries,
coltitle=white,
colbacktitle=warningred
}
% Goal box
\newtcolorbox{goalbox}[1][Treatment Goals]{
enhanced,
colback=green!5,
colframe=successgreen,
arc=3mm,
boxrule=1.5pt,
left=10pt,
right=10pt,
top=10pt,
bottom=10pt,
title=#1,
fonttitle=\sffamily\bfseries,
coltitle=white,
colbacktitle=successgreen
}
% Key points box
\newtcolorbox{keybox}[1][Key Points]{
enhanced,
colback=secondaryblue!10,
colframe=accentblue,
arc=3mm,
boxrule=1.5pt,
left=10pt,
right=10pt,
top=10pt,
bottom=10pt,
title=#1,
fonttitle=\sffamily\bfseries,
coltitle=white,
colbacktitle=accentblue
}
% Table styling
\newcommand{\tableheadercolor}{\rowcolor{primaryblue}}
\newcommand{\tablerowcolor}{\rowcolor{lightgray}}
% Custom table environment
\newenvironment{medtable}[1]{
\begin{table}[h]
\centering
\small\sffamily
\renewcommand{\arraystretch}{1.3}
}{
\end{table}
}
% Patient info section style
\newenvironment{patientinfo}{
\begin{tcolorbox}[
enhanced,
colback=white,
colframe=secondaryblue,
arc=2mm,
boxrule=1pt,
left=15pt,
right=15pt,
top=12pt,
bottom=12pt
]
\sffamily
}{
\end{tcolorbox}
}
% Custom list styling
\setlist[itemize,1]{label=\textcolor{primaryblue}{\textbullet}, leftmargin=*, itemsep=3pt}
\setlist[enumerate,1]{label=\textcolor{primaryblue}{\arabic*.}, leftmargin=*, itemsep=3pt}
% Emergency contact box
\newtcolorbox{emergencybox}{
enhanced,
colback=warningred!5,
colframe=warningred,
arc=3mm,
boxrule=2pt,
left=15pt,
right=15pt,
top=15pt,
bottom=15pt,
title=EMERGENCY CONTACTS,
fonttitle=\sffamily\bfseries\Large,
coltitle=white,
colbacktitle=warningred
}
\endinput
% One-Page Treatment Plan Template
% Concise, clinician-focused treatment recommendation
% Modeled after precision oncology reports and clinical decision support cards
% Last updated: 2025
\documentclass[10pt,letterpaper]{article}
% Minimal packages for clean, dense layout
\usepackage[top=0.5in,bottom=0.5in,left=0.6in,right=0.6in]{geometry}
\usepackage{amsmath,amssymb}
\usepackage[utf8]{inputenc}
\usepackage{graphicx}
\usepackage{array}
\usepackage{booktabs}
\usepackage{enumitem}
\usepackage{xcolor}
\usepackage{fancyhdr}
\usepackage{tabularx}
\usepackage[most]{tcolorbox}
\usepackage{multicol}
% Compact spacing
\setlist{nosep,leftmargin=*,itemsep=0pt,topsep=2pt}
\setlength{\parindent}{0pt}
\setlength{\parskip}{4pt}
% No page numbers for single page
\pagestyle{empty}
% Section formatting - compact
\usepackage{titlesec}
\titlespacing*{\section}{0pt}{8pt}{4pt}
\titlespacing*{\subsection}{0pt}{6pt}{3pt}
\titleformat{\section}{\normalsize\bfseries\sffamily}{\thesection}{0em}{}
\titleformat{\subsection}{\small\bfseries\sffamily}{\thesubsection}{0em}{}
% Color scheme
\definecolor{headerblue}{RGB}{0,102,153}
\definecolor{lightgray}{RGB}{240,240,240}
\definecolor{darkgray}{RGB}{80,80,80}
\begin{document}
% ========== TITLE ==========
\begin{center}
{\small\textit{PRECISION MEDICINE / CLINICAL RECOMMENDATION}}\\[2pt]
{\Large\bfseries\sffamily [Treatment Type]}\\[1pt]
{\normalsize\textit{[Condition/Disease Name]}}
\end{center}
\vspace{-8pt}
% ========== PATIENT/CASE INFO BOX ==========
\begin{tcolorbox}[
colback=lightgray,
colframe=headerblue,
boxrule=0.5pt,
arc=2pt,
left=4pt,right=4pt,top=3pt,bottom=3pt,
fontupper=\small
]
\textbf{Patient ID:} [De-identified ID] \hfill \textbf{Date:} \today\\
\textbf{Diagnosis:} [Primary diagnosis + ICD-10] \hfill \textbf{Stage/Grade:} [If applicable]\\
\textbf{Age/Sex:} [Age range, sex] \hfill \textbf{Molecular Profile:} [Key biomarkers or cluster, if applicable]
\end{tcolorbox}
\vspace{4pt}
% ========== TWO-COLUMN LAYOUT FOR EFFICIENCY ==========
\begin{multicols}{2}
% ========== LEFT COLUMN ==========
\section*{TARGET PATIENT POPULATION}
{\small
\textbf{Number of Patients:} [N (\% of cohort)]\\
\textbf{Key Features:} [Brief demographic or clinical features]\\
\textbf{Inclusion Criteria:} [1-2 key criteria]
}
\section*{PRIMARY TREATMENT REGIMEN}
{\small
\begin{enumerate}[leftmargin=12pt]
\item \textbf{[Intervention 1]:} [Specific details]
\begin{itemize}
\item Dose: [specific dosing]
\item Frequency: [schedule]
\item Duration: [timeframe]
\end{itemize}
\item \textbf{[Intervention 2]:} [Specific details]
\begin{itemize}
\item [Key parameters]
\end{itemize}
\item \textbf{[Intervention 3]:} [Optional, if needed]
\begin{itemize}
\item [Key parameters]
\end{itemize}
\end{enumerate}
}
\section*{SUPPORTIVE CARE}
{\small
\begin{itemize}
\item \textbf{[Supportive Med 1]:} [dose/frequency]
\item \textbf{[Supportive Med 2]:} [dose/frequency]
\item \textbf{[Other support]:} [brief description]
\end{itemize}
}
\section*{RATIONALE}
{\small
[1-3 sentences explaining why this regimen is appropriate for this patient. Include key pathophysiology, guideline alignment, or molecular rationale if applicable.]
}
\columnbreak
% ========== RIGHT COLUMN ==========
\section*{MOLECULAR TARGETS / RISK FACTORS}
{\small
\begin{itemize}
\item \textbf{[Target/Factor 1]:} [Value/status]
\item \textbf{[Target/Factor 2]:} [Value/status]
\item \textbf{[Target/Factor 3]:} [Value/status]
\end{itemize}
}
\section*{EVIDENCE LEVEL}
{\small
\textbf{[Level designation - e.g., Level 1, FDA approved]}\\
\textbf{Supporting Evidence:} [Guideline name/year or key trial]\\
\textbf{References:} [1-2 key citations in abbreviated format]
}
\section*{MONITORING REQUIREMENTS}
{\small
\begin{tabular}{@{}ll@{}}
\textbf{Parameter} & \textbf{Frequency} \\
\hline
[Lab/vital 1] & [e.g., Weekly x 4 weeks] \\
[Lab/vital 2] & [e.g., Monthly x 3 months] \\
[Lab/vital 3] & [e.g., Every 3 months] \\
[Assessment tool] & [e.g., Baseline, 3 mo, 6 mo] \\
\end{tabular}
}
\section*{EXPECTED CLINICAL BENEFIT}
{\small
\textbf{Primary Outcome:} [e.g., Median OS 20.9 months]\\
\textbf{Timeline:} [e.g., Response assessment at 12 weeks]\\
\textbf{Success Criteria:} [Specific metrics for goal achievement]
}
\section*{CRITICAL DECISION POINTS}
{\small
\begin{itemize}
\item \textbf{Hold treatment if:} [Specific criteria]
\item \textbf{Dose modify for:} [Specific criteria]
\item \textbf{Discontinue if:} [Specific criteria]
\end{itemize}
}
\end{multicols}
\vspace{4pt}
% ========== BOTTOM SECTION - FULL WIDTH ==========
\begin{tcolorbox}[
colback=yellow!10,
colframe=red!60!black,
boxrule=0.8pt,
arc=2pt,
left=4pt,right=4pt,top=3pt,bottom=3pt,
fontupper=\small\bfseries
]
\textbf{EMERGENCY CONTACTS / URGENT CONCERNS:} \\
{\small\normalfont
Call [clinic/provider] immediately for: [List 2-3 red flag symptoms]. \\
Emergency: 911 | Clinic: [phone] | After-hours: [phone] | Pharmacy: [phone]
}
\end{tcolorbox}
\vspace{6pt}
{\footnotesize\textit{
Prepared by: [Provider name, credentials] | Plan created: \today | Next review: [date] \\
HIPAA Notice: This document contains de-identified patient information per Safe Harbor standards.
}}
\end{document}
Treatment Plan Quality Assurance Checklist
Overview
Use this checklist to ensure treatment plans meet professional standards for completeness, quality, safety, and regulatory compliance. Review each section before finalizing the plan.
---
Section 1: Completeness - Required Components
☐ Patient Information
- [ ] Patient identifier (de-identified if sharing)
- [ ] Age range (not exact date of birth)
- [ ] Sex and relevant demographics
- [ ] Date of plan creation
- [ ] Provider name and credentials
- [ ] Facility/practice name
- [ ] HIPAA de-identification notice included
☐ Diagnosis and Assessment
- [ ] Primary diagnosis clearly stated
- [ ] ICD-10 code(s) included
- [ ] Secondary diagnoses and comorbidities listed
- [ ] Disease severity/staging documented
- [ ] Baseline functional status assessed
- [ ] Risk stratification performed (if applicable)
☐ Treatment Goals
- [ ] Short-term goals present (1-3 months)
- [ ] Long-term goals present (6-12 months)
- [ ] Goals meet SMART criteria (see Section 2)
- [ ] Patient-centered goals included
- [ ] Goals are prioritized or organized
☐ Interventions
- [ ] Pharmacological interventions specified
- [ ] Non-pharmacological interventions included
- [ ] Procedural interventions or referrals noted
- [ ] Each intervention has clear rationale
- [ ] Evidence-based or guideline-concordant
☐ Timeline and Schedule
- [ ] Treatment phases with durations defined
- [ ] Appointment frequency specified
- [ ] Milestone assessments scheduled
- [ ] Expected total treatment duration stated
☐ Monitoring Parameters
- [ ] Clinical outcomes to track identified
- [ ] Baseline values documented
- [ ] Target values specified
- [ ] Monitoring frequency defined
- [ ] Assessment tools/scales named
☐ Expected Outcomes
- [ ] Primary outcome measures stated
- [ ] Success criteria defined
- [ ] Timeline for improvement indicated
- [ ] Criteria for treatment modification noted
☐ Follow-up Plan
- [ ] Next appointment scheduled
- [ ] Follow-up frequency specified
- [ ] Communication plan outlined
- [ ] Emergency contact procedures included
☐ Patient Education
- [ ] Condition education documented
- [ ] Self-management skills training noted
- [ ] Warning signs communicated
- [ ] Resources and support listed
☐ Risk Mitigation and Safety
- [ ] Potential adverse effects identified
- [ ] Safety monitoring plan included
- [ ] Emergency procedures outlined
- [ ] Complication prevention addressed
☐ Signature and Date
- [ ] Provider signature line
- [ ] Provider name and credentials
- [ ] Date of plan
- [ ] Patient acknowledgment (if applicable)
---
Section 2: SMART Goals Quality
For each treatment goal, verify it meets SMART criteria:
☐ Specific
- [ ] Goal clearly defines what will be accomplished
- [ ] No vague language (e.g., "improve", "better")
- [ ] Specific outcome stated
Example: "Reduce HbA1c from 8.5% to <7%" ✓ Not: "Improve diabetes control" ✗
☐ Measurable
- [ ] Quantifiable metric or observable criterion included
- [ ] Baseline value documented
- [ ] Target value specified
Example: "Walk 300 feet with walker independently" ✓ Not: "Walk further" ✗
☐ Achievable
- [ ] Realistic given patient's condition and capabilities
- [ ] Resources available to support goal
- [ ] Timeframe is reasonable
- [ ] Treatment efficacy supports goal
Example: "Reduce pain from 7/10 to 4/10 in 6 weeks" ✓ Not: "Eliminate all pain in 1 week" ✗
☐ Relevant
- [ ] Aligned with patient values and priorities
- [ ] Clinically meaningful
- [ ] Addresses patient's functional limitations
- [ ] Integrated with overall treatment objectives
Example: "Return to work with modifications within 3 months" ✓ Not: "Lab value improvement" (if patient doesn't care about it) ✗
☐ Time-bound
- [ ] Specific deadline or timeframe stated
- [ ] Reassessment interval defined
- [ ] Action frequency specified (if applicable)
Example: "Within 8 weeks" or "By month 3" ✓ Not: "Eventually" or "Soon" ✗
---
Section 3: Clinical Quality
☐ Evidence-Based Practice
- [ ] Interventions based on current evidence
- [ ] Clinical practice guidelines followed
- [ ] Guideline deviations explained and justified
- [ ] Literature or evidence cited (if formal plan)
☐ Medication Documentation (if applicable)
- [ ] Generic drug names used
- [ ] Specific dose, route, frequency documented
- [ ] Indication/rationale provided for each medication
- [ ] Adverse effects to monitor noted
- [ ] Drug interactions considered
- [ ] Titration plan included if applicable
☐ Assessment Tools
- [ ] Validated assessment tools used when available
- [ ] Tools appropriate for condition (PHQ-9, FIM, Berg, etc.)
- [ ] Baseline scores documented
- [ ] Target scores specified
- [ ] Reassessment schedule defined
☐ Multidisciplinary Coordination (if applicable)
- [ ] Roles of team members defined
- [ ] Communication plan among providers specified
- [ ] Care transitions addressed
- [ ] Specialist recommendations integrated
☐ Preventive Care Integration
- [ ] Age-appropriate screening included
- [ ] Vaccination schedule noted
- [ ] Lifestyle counseling documented
- [ ] Health maintenance addressed
---
Section 4: Patient-Centered Care
☐ Shared Decision-Making
- [ ] Patient preferences documented
- [ ] Treatment options discussed
- [ ] Risks and benefits explained
- [ ] Patient values incorporated into goals
- [ ] Alternative treatments considered
☐ Health Literacy
- [ ] Language appropriate for patient understanding
- [ ] Medical jargon explained or avoided
- [ ] Teach-back method used or planned
- [ ] Written materials at appropriate reading level
☐ Cultural Competence
- [ ] Cultural beliefs and practices considered
- [ ] Language barriers addressed (interpreter if needed)
- [ ] Cultural adaptations made when appropriate
- [ ] Religious/spiritual preferences respected
☐ Social Determinants of Health
- [ ] Social needs screened (food, housing, transportation)
- [ ] Barriers to care identified
- [ ] Community resources provided
- [ ] Financial concerns addressed (medication costs, etc.)
☐ Patient Engagement
- [ ] Patient actively involved in goal-setting
- [ ] Self-management support provided
- [ ] Patient education tailored to individual
- [ ] Follow-up preferences considered
---
Section 5: Safety and Risk Management
☐ Medication Safety
- [ ] Allergy history documented
- [ ] Polypharmacy reviewed (deprescribing considered)
- [ ] High-risk medications monitored appropriately
- [ ] Drug-drug interactions checked
- [ ] Renal/hepatic dosing adjustments made if needed
☐ Fall Prevention (if relevant)
- [ ] Fall risk assessed
- [ ] Fall prevention strategies included
- [ ] Environmental modifications recommended
- [ ] Assistive devices prescribed
☐ Infection Prevention (if relevant)
- [ ] Immunizations up to date
- [ ] Prophylactic antibiotics if indicated
- [ ] Infection signs and symptoms patient education
☐ Emergency Preparedness
- [ ] Emergency warning signs clearly listed
- [ ] When to call 911 specified
- [ ] When to call provider defined
- [ ] Emergency contact numbers provided
☐ Suicide/Violence Risk (mental health plans)
- [ ] Risk assessment documented
- [ ] Safety plan created if ideation present
- [ ] Means restriction addressed
- [ ] Crisis resources provided (988 lifeline)
- [ ] Follow-up frequency appropriate for risk level
☐ Opioid Safety (pain management plans)
- [ ] Opioid risk assessment completed (ORT, SOAPP)
- [ ] Informed consent discussion documented
- [ ] Treatment agreement signed
- [ ] PDMP checked
- [ ] Naloxone co-prescribed
- [ ] UDS plan included
---
Section 6: Regulatory Compliance
☐ HIPAA Compliance
- [ ] Protected health information (PHI) safeguarded
- [ ] De-identification per Safe Harbor method (if sharing)
- [ ] All 18 HIPAA identifiers removed (if de-identified)
- [ ] Minimum necessary principle followed
☐ Informed Consent
- [ ] Consent discussion documented
- [ ] Patient understanding verified
- [ ] Risks and benefits explained
- [ ] Alternative treatments discussed
- [ ] Patient agreement documented
☐ Medical Necessity
- [ ] Treatment medically necessary for diagnosis
- [ ] Interventions appropriate for severity
- [ ] Evidence supports treatment choices
- [ ] Frequency and duration justified
☐ Billing and Coding
- [ ] ICD-10 diagnosis codes included
- [ ] CPT procedure codes (if procedures planned)
- [ ] Documentation supports billing level
- [ ] Medical necessity for services demonstrated
☐ Quality Measure Support
- [ ] Elements support quality reporting (HEDIS, MIPS)
- [ ] Chronic disease management protocols followed
- [ ] Preventive care documented
- [ ] Patient safety indicators addressed
☐ Specialty-Specific Regulations
- [ ] 42 CFR Part 2 compliance (if substance use disorder treatment)
- [ ] CDC opioid guidelines followed (if opioid prescription)
- [ ] Joint Commission standards met (if applicable)
- [ ] State-specific requirements addressed
---
Section 7: Documentation Standards
☐ Clarity and Precision
- [ ] Professional medical terminology used appropriately
- [ ] Abbreviations defined on first use
- [ ] No ambiguous language
- [ ] Specific rather than vague descriptions
☐ Accuracy
- [ ] Factually correct information
- [ ] Current evidence-based recommendations
- [ ] Correct medication dosing and frequencies
- [ ] Proper ICD-10 and CPT coding
☐ Organization
- [ ] Logical flow and structure
- [ ] Consistent formatting
- [ ] Easy to locate key information
- [ ] Headings and sections clearly labeled
☐ Legibility (if handwritten or hybrid)
- [ ] Handwriting legible
- [ ] No unclear abbreviations
- [ ] Typed portions clear
- [ ] Signatures legible with printed name
☐ Authentication
- [ ] Provider name clearly stated
- [ ] Credentials included
- [ ] Date of plan present
- [ ] Signature obtained (electronic or handwritten)
---
Section 8: Special Considerations by Plan Type
For General Medical Plans:
- [ ] Chronic disease management protocols followed
- [ ] Guideline-based targets used (HbA1c, BP, lipids)
- [ ] Medication regimen optimized
- [ ] Comorbidities addressed
- [ ] Preventive care integrated
For Rehabilitation Plans:
- [ ] Functional assessments with validated tools (FIM, Berg)
- [ ] Impairment, activity, and participation goals included
- [ ] Therapy frequency and duration specified
- [ ] Home exercise program documented
- [ ] DME and environmental modifications listed
- [ ] Discharge criteria defined
For Mental Health Plans:
- [ ] DSM-5 diagnostic criteria met
- [ ] Symptom severity assessed (PHQ-9, GAD-7, etc.)
- [ ] Suicide/violence risk assessed
- [ ] Safety plan created (if indicated)
- [ ] Evidence-based psychotherapy specified
- [ ] Medication trials and responses documented
- [ ] Functional and recovery-oriented goals included
For Chronic Disease Management Plans:
- [ ] All active conditions prioritized
- [ ] Medication synergies identified
- [ ] Polypharmacy addressed
- [ ] Care coordination plan clear
- [ ] Registry/population health integration noted
- [ ] Transition management included
For Perioperative Plans:
- [ ] Preoperative risk assessment (RCRI, ASA, Caprini)
- [ ] Medical optimization documented
- [ ] ERAS elements included (if applicable)
- [ ] Postoperative milestones defined
- [ ] Discharge criteria specified
- [ ] VTE prophylaxis plan included
For Pain Management Plans:
- [ ] Comprehensive pain assessment (location, quality, intensity, impact)
- [ ] Pain type classified (nociceptive, neuropathic, nociplastic)
- [ ] Multimodal analgesia approach
- [ ] Opioid risk assessment (if opioids considered)
- [ ] Functional goals emphasized (not just pain scores)
- [ ] Psychological screening and intervention included
- [ ] CDC opioid guidelines followed (if prescribing)
---
Section 9: Final Review
☐ Proofreading
- [ ] Spelling and grammar checked
- [ ] No typos or errors
- [ ] Consistent terminology throughout
- [ ] Patient name correct throughout (if not de-identified)
☐ Completeness Verification
- [ ] All placeholder text replaced with patient-specific information
- [ ] All bracketed [fields] customized
- [ ] No "TBD" or "to be completed" items remaining
- [ ] All required sections complete
☐ Quality Assurance
- [ ] Plan reviewed by provider
- [ ] Peer review completed (if applicable)
- [ ] Compliance verification done
- [ ] Automated checks run (if available scripts used)
☐ Patient Review Preparation
- [ ] Patient-friendly summary prepared (if needed)
- [ ] Patient education materials gathered
- [ ] Consent forms ready for signature
- [ ] Questions anticipated and prepared to address
---
Scoring and Interpretation
Total Items: ~150 (varies by plan type)
Scoring:
- Count number of checked items
- Calculate percentage: (Checked / Total) × 100
Interpretation:
- 95-100%: Excellent - Plan meets highest quality standards
- 85-94%: Good - Plan is high quality with minor gaps
- 70-84%: Acceptable - Plan is adequate but has areas needing improvement
- <70%: Needs Improvement - Significant gaps in quality or compliance
Critical Items (Must Have):
The following items are critical and must be present:
- ✓ Patient identifier and de-identification notice
- ✓ Primary diagnosis with ICD-10 code
- ✓ At least 3 SMART goals
- ✓ Interventions with rationales
- ✓ Monitoring plan
- ✓ Follow-up plan
- ✓ Patient education
- ✓ Safety/risk mitigation
- ✓ Emergency procedures
- ✓ Provider signature
If any critical item is missing, plan should not be finalized until corrected.
---
Usage Instructions
1. Review each section systematically 2. Check boxes as criteria are met 3. Note deficiencies for correction 4. Calculate score to assess overall quality 5. Address gaps before finalizing 6. Document review with reviewer name and date
Reviewer: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Date Reviewed: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Score: \_\_\_\_\_% (\_\_\_\_ items checked / \_\_\_\_ total items)
Status:
- [ ] Approved for use
- [ ] Approved with minor revisions
- [ ] Requires significant revision
- [ ] Not approved
Comments/Recommendations:
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
---
Document Version: 1.0 Last Updated: January 2025 Next Review: Annually or with guideline updates